Document:

Exhibit 10.1

 

GENERAL MOLY, INC.

 

SECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) dated as of March 21, 2019, is made and entered into by and among General Moly, Inc., a Delaware corporation (the “Company”), and each of the persons (each an “Investor” and collectively the “Investors”) whose names are set forth on the Schedule of Investors attached hereto as Exhibit A (the “Schedule of Purchasers”).

 

RECITALS

 

WHEREAS, the Company desires to sell to the Investors, and the Investors desire to purchase, in aggregate, up to $900,000 of Preferred Shares (as defined below).

 

NOW, THEREFORE, In consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which hereby are acknowledged, the parties agree as follows:

 

AGREEMENT

 

1.                                      Certain Definitions:

 

“1933 Act” means the Securities Act of 1933, as amended.

 

“Affiliate” means, as to any Person, any other Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with such Person.  As used in this definition, “control” (including, with its correlative meanings, “controlled by” and “under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies (whether through ownership of securities or partnership or other ownership interests, by contract or otherwise).

 

“Agreement” has the meaning set forth in the Recitals.

 

“Audited Financial Statements” has the meaning set forth in Section 3.7(d).

 

“Blue Sky Laws” means any state securities or “blue sky” laws.

 

“Business Day” means any day other than a Saturday, Sunday or any other day on which The Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.

 

“Bylaws” has the meaning set forth in Section 3.2.

 

“Certificate of Designations” means the Certificate of Designations in the form that is attached hereto as Exhibit B.

 

“Certificate of Incorporation” has the meaning set forth in Section 3.2.

 

 

“Closing” has the meaning set forth in Section 2.2.

 

“Closing Date” has the meaning set forth in Section 2.2.

 

“Closing Notice” has the meaning set forth in Section 2.2.

 

“Common Stock” means the Company’s Common Stock, $0.001 par value per share, authorized as of the date hereof, and any stock of any class or classes (however designated) hereafter authorized upon reclassification thereof, which, if the Board of Directors declares a dividend or distribution, has the right to participate in the distribution of earnings and assets of the Company after the payment of dividends or other distributions on any shares of capital stock of the Company entitled to a preference and in the voting for the election of directors of the Company.

 

“Company” has the meaning set forth at the head of this Agreement and any corporation or other entity which shall succeed to or assume, directly or indirectly, the obligations of the Company hereunder.  The term “corporation” shall include an association, joint stock company, business trust, limited liability company or other similar organization.

 

“Contemplated Transactions” has the meaning set forth in Section 3.1(b).

 

“Exchange Act” means the Securities Exchange Act of 1934, as amended.

 

“Financial Statements” has the meaning set forth in Section 3.7(d).

 

“Governmental Body” shall mean any: (i) nation, state, commonwealth, province, territory, county, municipality, district or other jurisdiction of any nature in the United States; (ii) federal, state, local, municipal, foreign or other government; or (iii) governmental or quasi-governmental authority of any nature (including any governmental division, department, agency, commission, instrumentality, official, organization, unit, body or entity and any court or other tribunal) in the United States.

 

“Indemnified Party” has the meaning set forth in Section 6.2(b).

 

“Indemnifying Party” has the meaning set forth in Section 6.2(c).

 

“Investor” shall mean each Investor who purchases Securities hereunder.

 

“Investor Majority” shall mean (a) from the date hereof until the first Closing, Investors who have subscribed for a majority of the Preferred Shares then subscribed for and (b) thereafter, Investors (or their assignees in private transactions) who hold more than fifty percent (50%) of the Preferred Shares.

 

“Knowledge” shall mean, with respect to a particular fact or other matter, the knowledge, after reasonable investigation, of the Chief Executive Officer/Chief Financial Officer or Chief Operating Officer of the Company.

 

“Losses” has the meaning set forth in Section 6.2(b).

 

2

 

“Material Adverse Effect” has the meaning set forth in Section 3.1(a).

 

“Material Agreement” has the meaning set forth in Section 3.6.

 

“Person” means any individual, sole proprietorship, partnership, corporation, limited liability company, business trust, unincorporated association, joint stock corporation, trust, joint venture or other entity, any university or similar institution, or any government or any agency or instrumentality or political subdivision thereof.

 

“Preferred Shares” means shares of the Company’s Series A Preferred Stock, par value $0.001 per share, to be created pursuant to the Certificate of Designations.

 

“Rule 144” means Rule 144 promulgated under the 1933 Act or any successor or substitute rule, law or provision.

 

“SEC” means the Securities and Exchange Commission.

 

“SEC Documents” has the meaning set forth in Section 3.7(a).

 

“Subsidiary” means any significant subsidiary (as defined under Rule 1.02(w) of Regulation S-X promulgated by the SEC) of the Company.

 

“Transaction Documents” means this Agreement and the Certificate of Designations.

 

“Unaudited Financial Statements” has the meaning set forth in Section 3.7(d).

 

“Underlying Securities” means the shares of Common Stock that are issuable from time to time issuable upon conversion of the Preferred Shares.

 

2.                                      Purchase and Sale of Securities.

 

2.1                               Sale and Issuance of Securities.

 

(a)                                 The Company shall sell to the Investors, and the Investors shall purchase from the Company, Preferred Shares at a price equal to $100.00 per share, from time to time as set forth in more detail below.

 

(b)                                 The pro rata percentage of Preferred Shares to be purchased by each Investor at any given closing of a purchase and sale of the Preferred Shares hereunder (each, a “Closing”) is set forth in the Schedule of Investors that is attached hereto as Exhibit A.

 

2.2                               Closings.  The Company shall provide written notice (each, a “Closing Notice”) to each Investor specifying the date for any desired Closing, as well as the amount of Preferred Shares to be issued and sold at each Closing.  Each Closing shall take place on the date specified in the corresponding Closing Notice (such date to be no less than three (3) Business Days after the date of such Closing Notice), or such other date thereafter, as shall be determined by the Company with the

 

3

 

consent of the Investor Majority (the “Closing Date”).  Unless agreed to otherwise in writing by the Company and the Investor Majority: (a) no Closing Date may occur after June 30, 2019, (b) no Closing shall occur within 30 days of the most recent preceding Closing and (c) no single Closing shall be for greater than $300,000 of Preferred Shares.  The Closings shall each take place at the offices of Bryan Cave Leighton Paisner LLP, counsel to the Company, in Denver, Colorado, or at such other location as is mutually acceptable to the Investor Majority and the Company, subject to fulfillment of the conditions to the Closing set forth in the Agreement.  At the Closing:

 

(a)                                 each Investor purchasing Preferred Shares at each Closing shall deliver to the Company or its designees prior to each Closing by wire transfer or such other method of payment as the Company shall approve, an amount equal to the pro rata purchase price of Preferred Shares to be purchased by such Investor at such Closing; and

 

(b)                                 the Company shall deliver to each Investor the pro rata number of Preferred Shares registered in the name of the Investor, or in such nominee name(s) as designated by the Investor in writing, representing the number of Preferred Shares set forth opposite such Investor’s name on the signature page hereof.

 

2.3                               Investors’ Conditions to Closing.  The obligation of the Investors to complete the purchase of Preferred Shares at each Closing is subject to the Company delivering Preferred Shares as set forth in Section 2.2 and to fulfillment of the following conditions:

 

(a)                                 the representation and warranties of the Company set forth in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as of the applicable Closing Date as though made on and as of such Closing Date (except to the extent such representations and warranties speak as of an earlier date, in which case such representations and warranties shall be true and correct in all material respects as of such earlier date), and the Company shall have performed in all material respects all covenants and other obligations required to be performed by it under this Agreement at or prior to such Closing Date, and the Investors shall have received a certificate signed on behalf of the Company by an authorized officer of the Company to such effect; and

 

(b)                                 the Company shall have executed and delivered all other documents reasonably requested by counsel for the Investors.

 

2.4                               Company’s Conditions to Closing.  The obligation of the Company to complete the sale of the Preferred Shares at each Closing is subject to fulfillment of the following conditions:

 

4

 

(a)                                 the representation and warranties of the Investors set forth in this Agreement shall be true and correct as of the date of this Agreement and as of the applicable Closing Date as though made on and as of the Closing Date (except to the extent such representations and warranties speak as of an earlier date), in which case such representations and warranties shall be true and correct in all material respects as of such earlier date), and

 

(b)                                 such Investors shall have performed in all material respects all covenants and other obligations required to be performed by them under this Agreement, if any, at or prior to the Closing Date.

 

3.                                      Representations and Warranties of the Company.  The Company hereby represents and warrants to each of the Investors as follows:

 

3.1                               Corporate Organization; Authority; Due Authorization.

 

(a)                                 The Company (i) is a corporation duly organized, validly existing and in good standing under the laws of the State of Delaware, (ii) has the corporate power and authority to own or lease its properties as and in the places where its business is now conducted and to carry on its business as now conducted, and (iii) is duly qualified as a foreign corporation authorized to do business in every jurisdiction where the failure to so qualify, individually or in the aggregate, would have a material adverse effect on the operations, assets, liabilities, financial condition or business of the Company and its Subsidiaries taken as a whole (a “Material Adverse Effect”).

 

(b)                                 The Company (i) has the requisite corporate power and authority to execute, deliver and perform this Agreement and the other Transaction Documents to which it is a party and to incur the obligations herein and therein and (ii) has been authorized by all necessary corporate action to execute, deliver and perform this Agreement and the other Transaction Documents to which it is a party and to consummate the transactions contemplated hereby and thereby (the “Contemplated Transactions”).  This Agreement is and each of the other Transaction Documents will be on the Closing Date a valid and binding obligation of the Company enforceable in accordance with its terms except as limited by applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting the enforcement of creditors’ rights and the availability of equitable remedies (regardless of whether such enforceability is considered in a proceeding at law or equity).

 

3.2                               Capitalization.  As of the date hereof, the authorized capital stock of the Company consists of (a) six hundred fifty million (650,000,000) shares of Common Stock, $0.001 par value, of which 137,526,132 shares are issued and outstanding and (b) ten million (10,000,000) shares of preferred stock, $0.001 per value, of which none are issued and outstanding, 55,000 of which have been designated as the

 

5

 

Preferred Shares of which have been designated as the Preferred Shares.  Except as contemplated by this Agreement or as set forth in the SEC Documents, there are (A) no outstanding subscriptions, warrants, options, conversion privileges or other rights or agreements obligating the Company to purchase or otherwise acquire or issue any shares of capital stock of the Company (or shares reserved for such purpose), (B) no preemptive rights contained in the Company’s Certificate of Incorporation, as amended (the “Certificate of Incorporation”), the Company’s Amended and Restated Bylaws (the “Bylaws”) or contracts to which the Company is a party or other rights of first refusal with respect to the issuance of additional shares of capital stock of the Company, including without limitation the Preferred Shares and the Underlying Securities, and (C) no commitments or understandings (oral or written) of the Company to issue any shares, warrants, options or other rights to acquire any equity securities of the Company.  Except as set forth in the SEC Documents, no Persons have any anti-dilution rights of any kind, whether triggered by the Contemplated Transactions or otherwise.  To the Company’s Knowledge, except as set forth in the SEC Documents, none of the shares of Common Stock are subject to any stockholders’ agreement, voting trust agreement or similar arrangement or understanding.  Except as set forth in the SEC Documents, the Company has no outstanding bonds, debentures, notes or other obligations the holders of which have the right to vote (or which are convertible into or exercisable for securities having the right to vote) with the stockholders of the Company on any matter.

 

3.3                               Validity of Securities.  The issuance of the Preferred Shares has been duly authorized by all necessary corporate action on the part of the Company. The Certificate of Designations has been duly authorized by all necessary corporate action on the part of the Company and duly filed with the Secretary of State of the State of Delaware.

 

3.4                               Underlying Securities.  (a) The issuance of the Underlying Securities upon conversion of the Preferred Shares has been duly authorized, (b) the Underlying Securities prior to such conversion will have been duly reserved for issuance upon such exercise and (c) when so issued, the Underlying Securities will be validly issued, fully paid and non-assessable.

 

3.5                               Brokers and Finders. The Company has not retained any broker, investment banker or finder in connection with the Contemplated Transactions and will not owe any fees to any broker, investment banker or finder under a tail or similar covenant from an earlier engagement or financing.

 

3.6                               No Conflict; Required Filings and Consents.

 

(a)                                 The execution, delivery and performance of this Agreement and the other Transaction Documents by the Company do not, and the consummation by the Company of the Contemplated Transactions will not, (i) conflict with or violate the Certificate of Incorporation or the Bylaws of the Company or its Subsidiaries, (ii) conflict with or violate any law, rule, regulation,

 

6

 

order, judgment or decree applicable to the Company or its Subsidiaries or by which any property or asset of the Company or its Subsidiaries is bound or affected, or (iii) result in any breach of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, result in the loss of a material benefit under, or give to others any right of purchase or sale, or any right of termination, amendment, acceleration, increased payments or cancellation of, or result in the creation of a lien or other encumbrance on any property or asset of the Company or of any of its Subsidiaries pursuant to, any material note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which the Company or any of its Subsidiaries is a party or by which the Company or of any of its Subsidiaries or any property or asset of the Company or of any of its Subsidiaries is bound or affected (the “Material Agreements”); except, in the case of clauses (ii) and (iii) above, for any such conflicts, violations, breaches, defaults or other occurrences that would not prevent or delay consummation of any of the Contemplated Transactions in any material respect or otherwise prevent the Company from performing its obligations under this Agreement or any of the other Transaction Documents in any material respect, and would not, individually or in the aggregate, have a Material Adverse Effect.

 

(b)                                 The execution and delivery of this Agreement and the other Transaction Documents by the Company do not, and the performance of this Agreement and the other Transaction Documents and the consummation by the Company of the Contemplated Transactions will not, require, on the part or in respect of the Company, any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Body (as hereinafter defined) except for the filing of a Form D with the SEC and applicable requirements, if any, of the Exchange Act or Blue Sky Laws, and any approval required by applicable rules of the markets in which the Company’s securities are traded.

 

3.7                               SEC Documents; Financial Statements.

 

(a)                                 The information contained in the following documents, did not, as of the date of the applicable document, include any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances in which they were made, not misleading, as of their respective filing dates or, if amended, as so amended (the following documents, collectively, the “SEC Documents”), provided that the representation in this sentence shall not apply to any misstatement or omission in any SEC Document filed prior to the date of this Agreement which was superseded by a subsequent SEC Document filed prior to the date of this Agreement:

 

7

 

(i)                                     the Company’s Annual Report on Form 10-K for the year ended December 31, 2018; and

 

(ii)                                  the Company’s Current Reports on Form 8-K filed on January 22, 2019 and March 15, 2019.

 

(b)                                 The Company has filed all forms, reports and documents required to be filed by it with the SEC for the 12 months preceding the date of this Agreement, including without limitation the SEC Documents.  As of their respective dates, the SEC Documents filed prior to the date hereof complied as to form in all material respects with the applicable requirements of the 1933 Act, the Exchange Act, and the rules and regulations thereunder.

 

(c)                                  The Company’s Annual Report on Form 10-K for the year ended December 31, 2018, includes audited consolidated balance sheets as of December 31, 2018 and 2017, consolidated statements of operations and consolidated statements of cash flows for the one year periods then ended (the “Financial Statements”).

 

(d)                                 The Financial Statements (including the related notes and schedules thereto) fairly present in all material respects the consolidated financial position, the results of operations, retained earnings or cash flows, as the case may be, of the Company for the periods set forth therein (subject, in the case of the Unaudited Financial Statements, to normal year-end audit adjustments that would not be material in amount or effect), in each case in accordance with generally accepted accounting principles consistently applied during the periods involved, except as may be noted therein.

 

3.8                               Corporate Documents.  The Company’s Certificate of Incorporation and Bylaws, each as amended to date, which are certified as of the Closing Date are true, correct and complete and contain all amendments thereto.

 

4.                                      Representations and Warranties of the Investors.  Each Investor represents and warrants to the Company as follows:

 

4.1                               Authorization.  Such Investor (x) has full power and authority to execute, deliver and perform this Agreement and the other Transaction Documents to which it is a party and to incur the obligations herein and therein and (y) if applicable, has been authorized by all necessary corporate or equivalent action to execute, deliver and perform this Agreement and the other Transaction Documents and to consummate the Contemplated Transactions.  This Agreement is and each of the other Transaction Documents will be upon the execution and delivery by such Investor, a valid and binding obligation of such Investor enforceable in accordance with its terms, except as limited by applicable bankruptcy, reorganization, insolvency, moratorium or similar laws affecting the enforcement

 

8

 

of creditors’ rights and the availability of equitable remedies (regardless of whether such enforceability is considered in a proceeding at law or equity).

 

4.2                               Brokers and Finders.  Such Investor has either not retained an investment banker, broker or finder, or has provided the name and information concerning such entity to the Company on or prior to the Closing Date.

 

4.3                               No Governmental Review.  Such Investor understands that no United States Federal or state agency or any other Governmental Body has passed on or made any recommendation or endorsement of the Preferred Shares or the fairness or suitability of the investment in the Preferred Shares nor has any agency or other Governmental Body passed upon or endorsed the merits of the offering of the Preferred Shares.

 

4.4                               Accredited Investor Status. As more fully set forth in the Accredited Investor Questionnaire to be delivered by the Investor to the Company in the form attached hereto as Exhibit C, the Investor is an “accredited investor” as such term is defined in Regulation D promulgated under the Preferred Shares Act.  The information provided by the Investor in the Questionnaire is true, complete and correct in all respects.

 

4.5                               No Conflict; Required Filings and Consents.

 

(a)                                 The execution, delivery and performance of this Agreement and the other Transaction Documents by each Investor do not, and the consummation by such Investor of the Contemplated Transactions will not, (i) if such Investor is an entity, conflict with or violate the certificate of incorporation or the bylaws (or equivalent or comparable documents) of such Investor, (ii) conflict with or violate any law, rule, regulation, order, judgment or decree applicable to such Investor or by which any property or asset of such Investor is bound or affected, or (iii) result in any breach of or constitute a default (or an event which with notice or lapse of time or both would become a default) under, result in the loss of a material benefit under, or give to others any right of purchase or sale, or any right of termination, amendment, acceleration, increased payments or cancellation of, or result in the creation of a lien or other encumbrance on any property or asset of such Investor pursuant to, any note, bond, mortgage, indenture, contract, agreement, lease, license, permit, franchise or other instrument or obligation to which such Investor is a party or by which such Investor or any property or asset of such Investor is bound or affected; except, for any such conflicts, violations, breaches, defaults or other occurrences that would not prevent or delay consummation of any of the Contemplated Transactions in any material respect or otherwise prevent such Investor from performing its obligations under this Agreement or any of the other Transaction Documents in any material respect.

 

9

 

(b)                                 The execution and delivery of this Agreement and the other Transaction Documents by each Investor do not, and the performance of this Agreement and the other Transaction Documents and the consummation by such Investor of the Contemplated Transactions will not, require, on the part or in respect of such Investor, any consent, approval, authorization or permit of, or filing with or notification to, any Governmental Body.

 

5.                                      Securities Laws.

 

5.1                               Securities Laws Representations and Covenants of Investors.

 

(a)                                 Each Investor represents and warrants to the Company that: this Agreement is made by the Company with such Investor in reliance upon such Investor’s representation to the Company, which by such Investor’s execution of this Agreement such Investor hereby confirms, that the Preferred Shares to be received by such Investor will be acquired for investment for such Investor’s own account, not as a nominee or agent, and not with a view to the resale or distribution of any part thereof such that such Investors would constitute an “underwriter” under the 1933 Act; provided that this representation and warranty shall not limit (i) the Investor’s right to sell the Underlying Securities in compliance with an exemption from registration under the 1933 Act and in compliance with all applicable federal securities laws and Blue Sky Laws or (ii) the Investor’s rights to indemnification under this Agreement.

 

(b)                                 Each Investor understands and acknowledges that (i) the offering of the Preferred Shares pursuant to this Agreement will not be registered under the 1933 Act or qualified under any Blue Sky Laws on the grounds that the offering and sale of the Preferred Shares are exempt from registration and qualification, respectively, under the 1933 Act and the Blue Sky Laws, (ii) nothing in this Agreement or any of the other Transaction Documents or in any other materials presented by or on behalf of the Company to such Investor in connection with the purchase of Securities constitutes legal, tax or investment advice, (iii) such Investor has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of Securities and (iv) if the Preferred Shares have not been registered under the 1933 Act and Rule 144 is not applicable, any resale of the Preferred Shares under circumstances in which the seller (or the Person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder.

 

(c)                                  Each Investor covenants that, unless the Preferred Shares, the Underlying Securities or any other shares of capital stock of the Company received in respect of the foregoing have been registered, such Investor will not

 

10

 

dispose of such securities unless and until such Investor shall have notified the Company of the proposed disposition and shall have furnished the Company with an opinion of counsel reasonably satisfactory in form and substance to the Company to the effect that (i) such disposition will not require registration under the 1933 Act and (ii) appropriate action necessary for compliance with the 1933 Act, all applicable Blue Sky Laws and any other applicable state, local or foreign law has been taken; provided, however, that if an Investor provides such an opinion reasonably satisfactory in form and substance to the Company, the Company will bear the reasonable expense thereof.

 

(d)                                 Each Investor represents to the Company that: (i) such Investor is able to fend for itself in the Contemplated Transactions; (ii) such Investor has such knowledge and experience in financial and business matters as to be capable of evaluating the merits and risks of such Investor’s prospective investment in the Preferred Shares and has so evaluated the merits and risks of such investment; (iii) such Investor has the ability to bear the economic risks of such Investor’s prospective investment and can afford the complete loss of such investment; (iv) such Investor has had an opportunity to review the SEC Documents, together with the opportunity to obtain such additional information as it requested to verify the accuracy of the information contained therein or otherwise supplied to such Investor so that such Investor can make an informed investment decision with respect to an investment in the Preferred Shares; (v) such Investor has had access to officers of the Company and an opportunity to ask questions of and receive answers from such officers and has had all questions that have been asked by such Investor satisfactorily answered by the Company; and (vi) such Investor is not subscribing to purchase the Preferred Shares as a result of or subsequent to any advertisement, article, notice or other communication published in any newspaper, magazine or similar media or broadcast over television or radio, or presented at any seminar or meeting, or any solicitation of a subscription by a Person not previously known to such Investor in connection with investments in securities generally.

 

(e)                                  Each Investor represents to the Company that: such Investor: (i) was qualified at the time such Investor was offered the Preferred Shares, (ii) qualifies on the date hereof, and (iii) will qualify on the Closing Date, as an “accredited investor” as such term is defined under Rule 501 promulgated under the 1933 Act.

 

(f)                                   By acceptance hereof, each Investor acknowledges that the Preferred Shares, the Underlying Securities and any shares of capital stock of the Company received in respect of the foregoing held by it may not be sold by such Investor without registration under the 1933 Act or an exemption therefrom, and therefore such Investor may be required to hold such securities for an indeterminate period.

 

11

 

(g)                                  In connection with any transfer of Securities made by each Investor in compliance with the provisions of this Agreement, such Investor will cause each proposed transferee of such Securities to agree and take hold such Securities subject to the provisions of this Agreement.

 

(h)                                 The representations, warranties and covenants of each Investor in this Agreement are made severally and not jointly.

 

5.2                               Legends.  All certificates for the Preferred Shares and the Underlying Securities, and each certificate representing any shares of capital stock of the Company or other securities or property received in respect of the foregoing, whether by reason of a stock split or share reclassification thereof, a stock dividend thereon or otherwise, and each certificate for any such securities issued to subsequent transferees of any such certificate (unless otherwise permitted herein) shall bear the following legend, unless such securities have been registered under the 1933 Act:

 

“THE PREFERRED SHARES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AMENDED (THE “1933 ACT”), OR ANY STATE SECURITIES LAWS.  THESE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED IN THE ABSENCE OF (I) SUCH REGISTRATION OR (II) AN EXEMPTION THEREFROM AND, IF REQUESTED BY THE COMPANY, AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY TO THE EFFECT THAT SUCH REGISTRATION IS NOT REQUIRED.”

 

6.                                      Additional Covenants of the Company.

 

6.1                               Reports, Information, Securities.

 

(a)                                 The Company shall cooperate with each Investor in supplying such information as may be reasonably requested by such Investor to complete and file any information reporting forms presently or hereafter required by the SEC as a condition to the availability of the safe harbor pursuant to Rule 144 for the sale of any of the Preferred Shares, the Underlying Securities and shares of capital stock of the Company received in respect of the foregoing.

 

(b)                                 The Company shall keep reserved for issuance a sufficient number of authorized but unissued shares of Common Stock (or other securities or property into which the Preferred Shares are then convertible) so that the Preferred Shares may be converted or exercised to purchase Common Stock (or such other securities or property) at any time.

 

12

 

6.2                               Expenses; Indemnification.

 

(a)                                 The Company agrees to pay on the Closing Date and save the Investors harmless against liability for (i) the payment of any stamp or similar taxes (including interest and penalties, if any) that may be determined to be payable in respect of the execution and delivery of this Agreement, and the issue and sale of any Securities and the Underlying Securities, (ii) the expense of preparing and issuing the certificates for the Preferred Shares and the Underlying Securities, and (iii) the cost of delivering the Preferred Shares and the Underlying Securities of each Investor to such Investor’s address, insured in accordance with customary practice.  Each Investor shall be responsible for its out-of-pocket expenses arising in connection with the Contemplated Transactions.

 

(b)                                 The Company hereby agrees and acknowledges that the Investors have been induced to enter into this Agreement and to purchase the Preferred Shares hereunder, in part, based upon the representations, warranties, agreements and covenants of the Company contained herein.  The Company hereby agrees to pay, indemnify and hold harmless the Investors (each, an “Indemnified Party”) against all claims, losses and damages resulting from any and all legal or administrative proceedings, including without limitation, reasonable attorneys’ fees and expenses incurred in connection therewith (but in no event for more than one law firm, selected by the Investor Majority, for all the Investors) (collectively, “Losses”), resulting from a breach by the Company of any representation or warranty of the Company contained herein or the failure of the Company to perform any agreement or covenant made herein;

 

(c)                                  As soon as reasonably practicable after receipt by any Indemnified Party of notice of any Losses in respect of which the Company (the “Indemnifying Party”) may be required to provide indemnification thereof under this Section 6.2, the Indemnified Party shall give written notice thereof to the Indemnifying Party.  The Indemnified Party may, at its option, claim indemnity under this Section 6.2 as soon as a claim has been threatened by a third party, regardless of whether any actual Losses have been suffered, so long as counsel for such Indemnified Party shall in good faith determine that such claim is not frivolous and that the Indemnifying Party may be required to provide indemnification therefor as a result thereof and shall give notice of such determination to the Indemnifying Party.  The Indemnified Party shall permit the Indemnifying Party at the Indemnifying Party’s option and expense, to assume the defense of any such claim by counsel mutually and reasonably satisfactory to the Indemnifying Party and a majority in interest of the Indemnified Parties and to settle or otherwise dispose of the same; provided, however, that each Indemnified Party may at all times participate in such defense at such Indemnified Party’s expense; and provided further, however, that the Indemnifying Party shall not, in defense of any such claim, except with the prior written consent of the Indemnified Party, consent to the entry of any judgment or settlement that does not include as an unconditional term

 

13

 

thereof the giving by the claimant or plaintiff in question to such Indemnified Party of a release of all liabilities in respect of such claim.  If the Indemnifying Party does not promptly assume the defense of such claim or if any such counsel is unable to represent one or more of the Indemnified Parties due to a conflict of interest, then an Indemnified Party may assume, to the extent separable, the defense of such portion of the claim as to which the conflict arose (and, if not separable, the entire claim) and be entitled to indemnification and prompt reimbursement from the Indemnifying Party for such Indemnified Party’s reasonable costs and expenses incurred in connection therewith, including without limitation, reasonable attorneys’ fees and expenses (not to exceed the cost of more than one law firm for all Investors).  Such fees and expenses shall be reimbursed to the Indemnified Parties as soon as practicable after submission of invoices to the Indemnifying Party.

 

6.3                               Form D and Blue Sky.  The Company agrees to file a Form D with respect to the Preferred Shares as required under Regulation D promulgated under the 1933 Act and to promptly provide a copy thereof to the Investor who requests a copy after such filing by reference to the web site www.sec.gov maintained by the SEC.  The Company, on or before the Closing Date, shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for or to qualify the Preferred Shares for sale to the Investors at Closing pursuant to this Agreement under the applicable securities or “blue sky” laws of the states of the United States (or to obtain an exemption from such qualification), and if requested by an Investor, shall provide evidence of any such action so taken.  The Company shall make such filings and reports relating to the offer and sale of the Preferred Shares, including but not limited to Form D if required in any state, as required under applicable Blue Sky laws following or on the Closing Date.  No Investor shall incur any costs or expenses relating to Form D or such filings under applicable Blue Sky laws.

 

6.4                               Listing on Securities Exchanges.  In furtherance and not in limitation of any other provision of this Agreement, during any period of time in which the Company’s Common Stock is listed on any national securities exchange, the Company will, at its expense, exercise its best efforts to simultaneously list on such exchange, upon conversion of the Preferred Shares, and maintain such listing, all Underlying Securities.

 

6.5                               Use of Proceeds.  The Company shall use the proceeds from the offering and sale of Preferred Shares hereunder for general corporate purposes.

 

7.                                      Miscellaneous.

 

7.1                               Entire Agreement; Successors and Assigns.  This Agreement and the other Transaction Documents constitute the entire contract between the parties relative to the subject matter hereof and thereof, and no party shall be liable or bound to the other in any manner by any warranties or representations (express or implied)

 

14

 

or agreements or covenants except as specifically set forth herein or therein.  This Agreement and the other Transaction Documents supersede any previous agreement among the parties with respect to the subject matter hereof and thereof.  The terms and conditions of this Agreement shall inure to the benefit of and be binding upon the respective executors, administrators, heirs, successors and assigns of the parties.  Nothing in this Agreement, expressed or implied, is intended to confer upon any party, other than the parties hereto, any rights, remedies, obligations or liabilities under or by reason of this Agreement.

 

7.2                               Survival of Representations and Warranties.  Notwithstanding any right of the Investors fully to investigate the affairs of the Company and notwithstanding any knowledge of facts determined or determinable by any Investor pursuant to such right of investigation, each Investor has the right to rely fully upon the representations, warranties, covenants and agreements of the Company contained in this Agreement or in any documents delivered pursuant to this Agreement.  All such representations and warranties of the Company contained in this Agreement shall survive the execution and delivery of this Agreement and the Closing hereunder and shall continue in full force and effect until the earlier of (a) the date that is one year after the Closing and (b) the sale of all of the Underlying Securities pursuant to Rule 144 under the 1933 Act or an effective registration statement under the 1933 Act covering the Underlying Securities.  All representations and warranties of the Investors contained in this Agreement shall survive the execution and delivery of this Agreement and the applicable Closing hereunder and shall continue in full force and effect until the date that is one year after the Closing.  The covenants of the Investors and the Company set forth in this Agreement shall survive the applicable Closing.

 

7.3                               Governing Law; Waiver of Jury Trial.  This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware without regard to its conflict of laws principles.  The parties hereto hereby agree to be subject to the exclusive personal jurisdiction in the federal and state courts of the State of Colorado or the State of Delaware and any award which may be enforced in regard to this Agreement may be enforced in such federal and state courts of the State of Colorado or the State of Delaware.  Each of the parties hereto hereby agrees to irrevocably and unconditionally waive trial by jury in any judicial proceeding between or among the parties arising out of or related to the Contemplated Transactions.

 

7.4                               Counterparts.  This Agreement may be executed (including by facsimile transmission) with counterpart signature pages or in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

7.5                               Headings.  The headings of the sections of this Agreement are for convenience and shall not by themselves determine the interpretation of this Agreement.

 

15

 

7.6                               Notices.  Any notice required or permitted to be given under this Agreement by any party shall be sufficiently given if delivered either (a) by electronic mail at such party’s electronic email address set forth below, or (b) by nationally recognized overnight express company, at such party’s physical address set forth below.  All such notices and other communications shall, when mailed by means of any nationally recognized overnight express company, be effective when delivered to the notice address (as evidenced by any signature for delivery at the notice address), or, if sent by electronic mail during the recipient’s normal business hours, when such notice is sent, and if such notice is sent by electronic mail after the recipient’s normal business hours, then on the next day.  Either party hereto may change its address specified for notices herein by designating a new address by notice in accordance with this Section 7.6.

 

7.7                               Rights of Transferees.  Any and all rights and obligations of each of the Investors herein incident to the ownership of Securities or the Underlying Securities shall pass successively to all subsequent transferees of such securities until extinguished pursuant to the terms hereof; provided, however, that no Investor may transfer or assign its rights under this Agreement (other than to an Affiliate) between the date of this Agreement and the Closing Date.

 

7.8                               Severability.  Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable law, but if any provision of this Agreement shall be deemed prohibited or invalid under such applicable law, such provision shall be ineffective to the extent of such prohibition or invalidity, and such prohibition or invalidity shall not invalidate the remainder of such provision or any other provision of this Agreement.

 

7.9                               Fees and Expenses.  Each party hereto shall pay its own (and its Affiliates’) legal, accounting and other fees, costs and expenses in connection with the Contemplated Transactions, including the fees, costs and expenses of their respective advisors or other representatives in connection with consultation or communication with or other assistance to the other party or its advisors or representatives.

 

7.10                        Amendments and Waivers.  Unless a particular provision or section of this Agreement requires otherwise explicitly in a particular instance, any provision of this Agreement may be amended and the observance of any provision of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), only with the written consent of the Company and the Investor Majority.  Any amendment or waiver effected in accordance with this Section 7.10 shall be binding upon each Investor, each holder of any Securities at the time outstanding (including without limitation securities into which any such Securities are convertible or exercisable), each future holder thereof, and the Company.

 

7.11                        Construction.  Words (including capitalized terms defined herein) in the singular shall be held to include the plural and vice versa as the context requires.  The

 

16

 

words “herein,” “hereinafter,” “hereunder” and words of similar import used in this Agreement shall, unless otherwise stated, refer to this Agreement as a whole and not to any particular provision of this Agreement.  The words “or” and “any” are not exclusive.  All references to “$” in this Agreement and the other agreements contemplated hereby shall refer to United States dollars (unless otherwise specified expressly).  Any reference to any gender includes the other genders.

 

[Remainder of page intentionally left blank; signature page attached.]

 

17

 

IF the PREFERRED SHARES will be held as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY, please complete the following:

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

 

	
 
    	
 
    	
Bruce D.   Hansen
    
	
 
    	
 
    	
Print Name   of Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ Bruce   D. Hansen 
    
	
 
    	
 
    	
Signature   of Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Social   Security Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Bong T.   Hansen
    
	
 
    	
 
    	
Print Name   of Spouse or Other Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ Bong T.   Hansen
    
	
 
    	
 
    	
Signature   of Spouse or Other Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Social   Security Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Address and   Fax Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
E-mail   Address
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
State of   Domicile: 
    	
Colorado
    

 

Accepted and Agreed to as of the date first above written:

 

	
GENERAL MOLY, INC.
    	
 
    	
Address for notices:
    1726 Cole Blvd., Suite 115
   Lakewood, CO 80401
    
	
By:
    	
 
    	
/s/ R. Scott Roswell
    	
 
    	
Attention: R. Scott Roswell
    
	
 
    	
 
    	
 
    	
 
    	
Telephone: (303) 928-8599
    
	
Name:
    	
 
    	
/s/ R. Scott Roswell
    	
 
    	
Email: sroswell@generalmoly.com
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Title:
    	
 
    	
Chief Legal Officer
    	
 
    	
with a copy to:
    
	
 
    	
 
    	
 
    	
 
    	
Bryan Cave Leighton Paisner LLP
    
	
Date:
    	
 
    	
March 28, 2019
    	
 
    	
1700 Lincoln Street, Suite 4100
    
	
 
    	
 
    	
Denver, CO 80203
    
	
 
    	
 
    	
Attention: Charles D. Maguire, Jr.
    
	
 
    	
 
    	
Telephone: (303) 866-0550
    
	
 
    	
 
    	
Email: charles.maguire@bclplaw.com
    

 

[Signature Page to Securities Purchase Agreement]

 

18

 

IF the PREFERRED SHARES will be held as JOINT TENANTS, as TENANTS IN COMMON, or as COMMUNITY PROPERTY, please complete the following:

 

IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date first above written.

 

	
 
    	
 
    	
Robert I.   Pennington
    
	
 
    	
 
    	
Print Name   of Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ R.   Pennington 
    
	
 
    	
 
    	
Signature   of a Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Social   Security Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Dolores R.   Pennington
    
	
 
    	
 
    	
Print Name   of Spouse or Other Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
/s/ Dolores   R. Pennington
    
	
 
    	
 
    	
Signature   of Spouse or Other Purchaser
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Social   Security Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
Address and   Fax Number
    
	
 
    	
 
    	
 
    
	
 
    	
 
    	
State of   Domicile: 
    	
Arizona
    

 

Accepted and Agreed to as of the date first above written:

 

	
GENERAL   MOLY, INC.
    	
 
    	
Address for   notices:
    1726 Cole Blvd., Suite 115
   Lakewood, CO 80401
    
	
By:
    	
 
    	
/s/ R.   Scott Roswell
    	
 
    	
Attention:   R. Scott Roswell
    
	
 
    	
 
    	
 
    	
 
    	
Telephone:   (303) 928-8599
    
	
Name:
    	
 
    	
/s/ R.   Scott Roswell
    	
 
    	
Email:   sroswell@generalmoly.com
    
	
 
    	
 
    	
 
    	
 
    	
 
    
	
Title:
    	
 
    	
Chief Legal   Officer
    	
 
    	
with a copy to:
    
	
 
    	
 
    	
Bryan Cave   Leighton Paisner LLP
    
	
Date:
    	
 
    	
March 28,   2019
    	
 
    	
1700   Lincoln Street, Suite 4100
    
	
 
    	
 
    	
 
    	
 
    	
Denver, CO   80203
   Attention: Charles D. Maguire, Jr.
   Telephone: (303) 866-0550
   Email: charles.maguire@bclplaw.com
    

 

[Signature Page to Securities Purchase Agreement]

 

19

 

Exhibit A

 

Schedule of Investors

 

	
INVESTOR NAME
    	
 
    	
PERCENTAGE OF SHARES
   PURCHASED
    	
 
    
	
 
    	
 
    	
 
    	
 
    
	
Bruce D. Hansen
    	
 
    	
88.9
    	
%
    
	
Robert I. Pennington
    	
 
    	
11.1
    	
%
    
	
TOTAL:
    	
 
    	
100
    	
%
    

 

 

Exhibit B

 

Form of Certificate of Designations

 

 

Exhibit C

 

Accredited Investor Questionnaire

 

To ensure that the Preferred Shares are sold pursuant to an appropriate exemption from registration under applicable Federal and State securities laws, the Investor is furnishing certain additional information by checking each boxes below preceding any statement below that is applicable to the Investor.  The Investor certifies that the information contained in each of the following checked statements (to be checked by the investor only if applicable) is true and correct and hereby agrees to notify the Company of any changes that may occur in such information prior to the Company’s acceptance of any subscription.

 

1.                                      [  ]                                            The Investor is a natural person whose individual net worth or joint net worth with his or her spouse as of the date hereof is in excess of $1,000,000. For purposes of this item 1, “net worth” means the excess of total assets at fair market value (including personal and real property, but excluding the estimated fair market value of a person’s primary home) over total liabilities. Total liabilities excludes any mortgage on the primary home in an amount of up to the home’s estimated fair market value as long as the mortgage was incurred more than 60 days before the Preferred Shares are purchased, but includes (i) any mortgage amount in excess of the home’s fair market value and (ii) any mortgage amount that was borrowed during the 60-day period before the closing date for the sale of Securities for the purpose of investing in the Preferred Shares.

 

2.                                      [  ]                                            The Investor is a natural person who had an individual income in excess of $200,000 in each of the two most recently completed years or joint income with his or her spouse in excess of $300,000 in each of those years and has reasonable expectation of reaching the same income level in the current year.

 

3.                                      [  ]                                            The Investor is a director or an executive officer of the Company.

 

4.                                      [  ]                                            The Investor is an organization described in section 501(c)(3) of the Internal Revenue Code, corporation, Massachusetts or similar business trust, or partnership not formed for the specific purpose of investing in the Preferred Shares, with total assets in excess of $5,000,000.

 

5.                                      [  ]                                            The Investor is a trust, with total assets in excess of $5,000,000, not formed for the specific purpose of acquiring the Preferred Shares, and the investment in the Preferred Shares is being directed by a sophisticated person, which, for purposes of this representation, means a person who has such knowledge and experience in financial and business matters that the person is capable of evaluating the merits and risks of the prospective investment in the Preferred Shares

 

 

6.                                      [  ]                                            The Investor is an employee benefit plan within the meaning of the Employee Retirement Income Security Act of 1974 (“ERISA”), and either the decision to invest in the Preferred Shares has been made by a plan fiduciary, as defined in Section 3(21) of ERISA, which is either a bank, savings and loan association, insurance company or registered investment advisor, or the employee benefit plan has total assets in excess of $5,000,000, or if a self-directed plan, investment decisions are made solely by persons who are accredited investors.

 

7.                                      [  ]                                            The Investor is a private business development company as defined in Section 202 (a)(22) of the Investment Advisers Act of 1940.

 

8.                                      [  ]                                            The Investor is a bank, as defined in Section 3(a)(2) of the Act, or a savings and loan association or other institution as defined in Section 3(a)(5)(A) of the Act whether acting in its individual or fiduciary capacity.

 

9.                                      [  ]                                            The Investor is a broker or dealer registered pursuant to Section 15 of the Preferred Shares Exchange Act of 1934, as amended.

 

10.                               [  ]                                            The Investor is an insurance company as defined in Section 2(13) of the Act.

 

11.                               [  ]                                            The Investor is an investment company registered under the Investment Company Act of 1940 or a business development company as defined in Section 2(a)(48) of that Act.

 

12.                               [  ]                                            The Investor is a Small Business Investment Company licensed by the U. S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958.

 

13.                               [  ]                                            The Investor is a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000.

 

14.                               [  ]                                            The Investor is an entity in which each of the equity owners is an accredited investor as defined in Rule 501(a) of Regulation D promulgated under the Act.   If you checked this Item 14, please complete the following part of this question:

 

(1) List all equity owners:

 

(2) What is the type of entity?EX-10.1

 Exhibit 10.1 

STERIS plc 
 2006
LONG-TERM EQUITY INCENTIVE PLAN 
 (As Assumed, Amended and Restated Effective March 28, 2019) 

On November 2, 2015, the business combination (the “Combination”) of STERIS Corporation (“STERIS Corp.”) and Synergy
Health plc (“Synergy”) was completed. Pursuant to the Combination, STERIS Corp. and Synergy became wholly owned subsidiaries of STERIS plc, a public limited company organized under the laws of England and Wales (“STERIS UK”), and
each outstanding Common Share (as hereinafter defined) was converted into the right to receive one STERIS UK Ordinary Share (as hereinafter defined). In connection with the Combination, the STERIS 2006 Long-Term Equity Incentive Plan (the
“Prior STERIS Corp. Plan”) and all awards then outstanding under the Prior STERIS Corp. Plan were assumed by STERIS UK. 
 On
March 28, 2019, the redomiciliation of STERIS UK from the United Kingdom to Ireland (the “Redomiciliation”) pursuant to a court-approved scheme of arrangement under English law (the “Scheme”) was completed. Pursuant to
the Redomiciliation, (a) STERIS UK became an indirect subsidiary of a public limited company incorporated under the laws of Ireland, also named STERIS plc (“STERIS IE”), (b) each outstanding STERIS UK Ordinary Share was cancelled and
(c) STERIS UK shareholders received one Ordinary Share (as hereinafter defined) for each STERIS UK Ordinary Share they held before the Redomiciliation. In connection with the Redomiciliation, the STERIS plc 2006 Long-Term Equity Incentive Plan
maintained by STERIS UK (the “Prior STERIS UK Plan”) and all awards then outstanding under the Prior STERIS UK Plan were assumed by STERIS IE. 

In connection with such assumption, upon the Scheme becoming effective: (i) each Option Right (as hereinafter defined) to acquire STERIS
UK Ordinary Shares granted under the Prior STERIS UK Plan, whether vested or unvested, that was outstanding immediately prior to the Scheme becoming effective ceased to represent an Option Right to acquire STERIS UK Ordinary Shares and was converted
into an Option Right to acquire that number of Ordinary Shares equal to the number of STERIS UK Ordinary Shares subject to such Option Right immediately prior to the Scheme becoming effective, at an exercise price per share equal to the per share
exercise price applicable to such Option Right immediately prior to the Scheme becoming effective; (ii) each Appreciation Right (as hereinafter defined) with respect to STERIS UK Ordinary Shares granted under the Prior STERIS UK Plan, whether
vested or unvested, that was outstanding immediately prior to the Scheme becoming effective ceased to represent an Appreciation Right with respect to STERIS UK Ordinary Shares and was converted into an Appreciation Right with respect to that number
of Ordinary Shares equal to the number of STERIS UK Ordinary Shares subject to such Appreciation Right immediately prior to the Scheme becoming effective, at an exercise price per share equal to the per share exercise price applicable to such
Appreciation Right immediately prior to the Scheme becoming effective; (iii) each STERIS UK Ordinary Share that was designated a restricted STERIS UK Ordinary Share granted under the Prior STERIS UK Plan was, under the Scheme, cancelled and the
holder of each such STERIS UK Ordinary Share designated as a restricted STERIS UK Ordinary Share received one Ordinary Share in consideration for each STERIS UK Ordinary Share that was designated a restricted STERIS UK Ordinary Share so cancelled;
and (iv) each Restricted Stock Unit (as hereinafter defined) granted under the Prior STERIS UK Plan that was outstanding immediately prior to the Scheme becoming effective ceased to represent a Restricted Stock Unit with respect to STERIS UK
Ordinary Shares and was converted into a Restricted Stock Unit with respect to that number of Ordinary Shares equal to the number of STERIS UK Ordinary Shares subject to the Restricted Stock Unit immediately prior to the Scheme becoming effective.
Except as required in order to comply with applicable law, each Option Right, Appreciation Right, share of Restricted Stock and Restricted Stock Unit shall continue to have, and shall continue to be subject to, the same terms and conditions that
were applicable to such Option Right, Appreciation Right, STERIS UK Ordinary Share that was designated a restricted STERIS UK Ordinary Share and Restricted Stock Unit, as applicable, immediately prior to the Scheme becoming effective (including,
settlement in cash or shares, as applicable). 
 Accordingly, upon the Scheme becoming effective, the Prior STERIS UK Plan is hereby
assumed, amended and restated as set forth herein, in order to reflect the actions described in the preceding two paragraphs. 
 1. Purpose. The
purpose of this STERIS plc 2006 Long-Term Incentive Plan is to attract and retain directors, officers and other employees of STERIS plc, a public limited company incorporated under the laws of Ireland, and its Subsidiaries and to provide to such
persons incentives and rewards for performance. This Plan, as assumed, amended and restated effective March 28, 2019, shall apply to all awards heretofore or hereafter granted hereunder or pursuant hereto, except as otherwise expressly provided
herein. 

 2. Definitions. As used in this Plan, 

 

	(a)	 “Acquisition Price” means such amount, if any, as may be specified by the Board in the Evidence of
Award with respect to Restricted Stock as the consideration to be paid by the Participant for such Restricted Stock, subject to adjustment pursuant to the provisions hereof; provided, that the par value of a share of Restricted Stock, if
required to be paid by a Participant, shall not constitute an Acquisition Price. 

  

	(b)	 “Appreciation Right” means a right in respect of Shares, including any right in respect of Common
Shares that was converted into a right in respect of STERIS UK Ordinary Shares and any right in respect of STERIS UK Ordinary Shares that was converted into a right in respect of Ordinary Shares, granted pursuant to Section 5 or Section 9
of this Plan, and will include both Free-Standing Appreciation Rights and Tandem Appreciation Rights. 

  

	(c)	 “Appreciation Right Expiration Date” means the date selected by the Board after which, except as
provided in Section 11(d) in the case of the death of the Participant to whom the Appreciation Right was granted, the Appreciation Right may not be exercised. 

 

	(d)	 “Base Price” means the price to be used as the basis for determining the Spread upon the exercise of
a Free-Standing Appreciation Right or a Tandem Appreciation Right. 

  

	(e)	 “Board” means the Board of Directors of the Company and, to the extent of any delegation by the Board
of Directors to the Compensation Committee of the Board of Directors or any other Committee of the Board of Directors (or subcommittee thereof) pursuant to Section 12 of this Plan or pursuant to the charter of any such Committee or otherwise,
such Committee (or subcommittee). 

  

	(f)	 “Cause” has the meaning specified in Section 2(n)(iv) hereof. 

 

	(g)	 “Chief Executive Officer” means the Chief Executive Officer of the Company. 

 

	(h)	 “Change in Control” has the meaning set forth in Section 14 of this Plan. 

 

	(i)	 “Code” means the U.S. Internal Revenue Code of 1986, as amended from time to time.

  

	(j)	 “Combination” has the meaning set forth in the first paragraph of this Plan. 

 

	(k)	 “Common Shares” means the shares of common stock, without par value, of STERIS Corp.

  

	(l)	 “Company” means STERIS IE in respect of periods from and after the Redomiciliation and STERIS UK or
STERIS Corp., as applicable, in respect of periods prior to the Redomiciliation. 

  

	(m)	 “Date of Grant” means the date specified by the Board or, in the case of awards permitted to be
granted hereunder by the Chief Executive Officer or his delegatee or delegatees, by the Chief Executive Officer or such delegatee or delegatees, on which a grant of Option Rights, Appreciation Rights, Performance Shares, Performance Units or other
awards contemplated by Section 10 of this Plan, or a grant or sale of Restricted Stock, Restricted Stock Units, or other awards contemplated by Section 10 of this Plan, will become effective (which date will not be earlier than the date on
which the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, takes action with respect thereto). 

  

	(n)	 “Detrimental Activity” means, in the case of any Participant who is a
Non-Employee Director or former Non-Employee Director, such activity, if any, as may be specified as a “Detrimental Activity” in any applicable Evidence of
Award of such Participant and, in the case of any Participant who is an Employee or former Employee, any of the following activities: 

  

	 	(i)	 Without the prior written consent of the Company, performing, either directly or indirectly, any advisory or
consulting services for, operating or investing in (other than not more than one percent of the stock in a publicly-held corporation that is traded on a recognized securities exchange or over-the-counter), being employed by or an independent contractor of, or being a director, partner, or officer of, or otherwise becoming associated with in any capacity, any person, firm, corporation,
partnership, proprietorship, or other entity that develops, manufactures, assembles, sells, distributes, or performs products, systems, or services in competition with any products, systems, or services developed, manufactured, assembled, sold,
distributed, or performed by the Company or a Subsidiary. 

  
 2 

	 	(ii)	 Without the prior written consent of the Company, directly or indirectly, inducing or attempting to induce any
employee, agent or other representative or associate of the Company or a Subsidiary to terminate his, her or its relationship with the Company or a Subsidiary or interfering with the relationship between the Company or a Subsidiary and any of its
employees, agents, representatives, suppliers, customers, or distributors. 

  

	 	(iii)	 Disclosing to anyone outside the Company or a Subsidiary, or using in other than the Company’s or a
Subsidiary’s business, without prior written authorization from the Company, any confidential data, marketing strategies (including customer lists), invention records, trade secrets, and other confidential information of the Company or a
Subsidiary, including, without limitation, information regarding customers, finances, or personnel, or concerning the products, systems, and services researched, developed, manufactured, assembled, sold, distributed, or performed by the Company or
otherwise concerning the business or affairs of the Company or a Subsidiary, acquired by the Participant during his or her employment with the Company or its Subsidiaries or while acting as a consultant for the Company or its Subsidiaries.

  

	 	(iv)	 An activity that results in a termination for Cause. Termination for “Cause” means, except as
otherwise provided in a Participant’s Evidence of Award, a termination: 

  

	 	(A)	 due to the Participant’s willful and continuous gross neglect of his or her duties for which he or she is
employed, 

  

	 	(B)	 due to an act of dishonesty on the part of the Participant resulting or intended to result, directly or
indirectly, in his or her material personal gain or enrichment at the expense of the Company or a Subsidiary, 

  

	 	(C)	 due to an act of theft in connection with the Participant’s employment with the Company or a Subsidiary,

  

	 	(D)	 due to any unauthorized disclosure of confidential information belonging to the Company or a Subsidiary,
including but not limited to any disclosure in violation of Section 2(n)(iii) hereof, or 

  

	 	(E)	 due to any material violation of any provisions of any Company policy or of any agreement with Company or any
Subsidiary. 

  

	 	(v)	 Such other activity as may be specified as constituting, or defined to be, “Detrimental Activity” in
the applicable Evidence of Award. 

  

	 	(vi)	 Any other conduct or act determined to be injurious, detrimental or prejudicial to any business, strategy,
personnel, reputation or other significant interest of the Company or any Subsidiary unless the Participant acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company.

  

	(o)	 “Director” means a member of the Board of Directors of the Company. 

 

	(p)	 “Effective Date” means July 26, 2006, the date this Plan initially became effective.

  

	(q)	 “Employee” means any individual employed by the Company or any Subsidiary. 

 

	(r)	 “Evidence of Award” means an agreement, certificate, resolution or other type or form of writing or
other evidence that sets forth the terms and conditions of the award granted and that is approved by the Board or, in the case of awards permitted to be granted hereunder by the Chief Executive Officer or his delegatee or delegatees, if applicable,
approved by such person. An Evidence of Award may be in an electronic medium, may be limited to notation on the books and records of the Company and, with the approval of the Board, need not be signed by a representative of the Company or a
Participant. 

  

	(s)	 “Exchange Act” means the U.S. Securities Exchange Act of 1934, as amended, and the rules and
regulations thereunder, as such law, rules and regulations may be amended from time to time. 

  

	(t)	 “Extended Exercise Period” has the meaning specified in Section 11(b)(i)(A).

  

	(u)	 “Free-Standing Appreciation Right” means an Appreciation Right granted pursuant to Section 5 or
Section 9 of this Plan that is not granted in tandem with an Option Right. 

  

	(v)	 “Good Standing” has the meaning specified in Section 11(b)(ii). 

 

	(w)	 “Incentive Stock Options” means Option Rights that are intended to qualify as “incentive stock
options” under Section 422 of the Code or any successor provision. 

  
 3 

	(x)	 “Incumbent Directors” means as of any time prior to the Redomiciliation, individuals who are then
Directors of the Company, and from and after the Redomiciliation, the individuals who, effective as of the Redomiciliation, are Directors of the Company and any individual becoming a Director subsequent to the Redomiciliation whose election,
nomination for election by the Company’s shareholders, or appointment, was approved by a vote of at least two-thirds of the then Incumbent Directors (either by a specific vote or by approval of the proxy
statement of the Company in which such person is named as a nominee for director, without objection to such nomination); provided, however, that an individual shall not be an Incumbent Director if such individual’s election or
appointment to the Board occurs as a result of an actual or threatened election contest (as described in Rule 14a-12(c) of the Exchange Act) with respect to the election or removal of Directors or other actual
or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board. 

  

	(y)	 “Management Objectives” means the measurable performance objective or objectives established pursuant
to this Plan for Participants who have received grants of Performance Shares or Performance Units or, when so determined by the Board, or, in the case of awards permitted to be granted hereunder by the Chief Executive Officer or his delegatee or
delegatees, Option Rights, Appreciation Rights, Restricted Stock, Restricted Stock Units, dividend equivalents and other awards pursuant to this Plan. Management Objectives may be described in terms of Company-wide objectives or objectives that are
related to the performance of the individual Participant or of the Subsidiary, segment, business unit, team, division, department, region or function within the Company or Subsidiary for which the Participant provides service. The Management
Objectives may be made relative to the performance of other companies, businesses or industries in respect of which the Participant provides service. If the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable,
determines that a change in the business, operations, corporate structure or capital structure of the Company, or the manner in which it conducts its business, or other events or circumstances render the Management Objectives unsuitable, the Board
or the Chief Executive Officer or his delegatee or delegatees, as applicable, may in its, his, her or their discretion modify such Management Objectives or the related levels of achievement, in whole or in part, as the Board or the Chief Executive
Officer or his delegatee or delegatees, as applicable, deems appropriate and equitable. 

  

	(z)	 “Market Value per Share” means, as of any particular date, the closing sales price per share of the
Shares as reported on the New York Stock Exchange Composite Tape or, if not listed on such exchange, on any other national securities exchange on which the Shares are listed. If there is no regular trading market for such Shares, the Market Value
per Share shall be determined by the Board or, in the case of awards permitted to be made by the Chief Executive Officer or his delegatee or delegatees, by the Chief Executive Officer or such delegatee or delegatees. 

 

	(aa)	 “Non-Employee Director” means a person who is a “non-employee director” of the Company within the meaning of Rule 16b-3 of the U.S. Securities and Exchange Commission promulgated under the Exchange Act.

  

	(bb)	 “Nonqualified Stock Options” means Option Rights intended by the Board not to qualify as
“incentive stock options” under Section 422 of the Code. 

  

	(cc)	 “Optionee” means the optionee named in an Evidence of Award evidencing an outstanding Option Right.

  

	(dd)	 “Option Expiration Date” means the date selected by the Board or, in the case of awards permitted to
be made by the Chief Executive Officer or his delegatee or delegatees, by the Chief Executive Officer or his delegatee or delegatees, after which, except as provided in Section 11(d) in the case of the death of the Participant to whom the
Option Right was granted, the Option Right may not be exercised. 

  

	(ee)	 “Option Price” means the purchase price payable on exercise of an Option Right, which Option Price
shall be specified in the Evidence of Award in respect of the relevant Option Right, subject to adjustment pursuant to the provisions hereof. 

  

	(ff)	 “Option Right” means the right to purchase Shares, including any right to purchase Common Shares that
was converted into a right to purchase STERIS UK Ordinary Shares and any right to purchase STERIS UK Ordinary Shares that was converted into a right to purchase Ordinary Shares, upon exercise of an option granted pursuant to Section 4 or
Section 9 of this Plan. 

  

	(gg)	 “Ordinary Shares” means the ordinary shares of STERIS IE or any security into which such ordinary
shares may be changed by reason of any transaction or event of the type referred to in Section 13 of this Plan. 

  
 4 

	(hh)	 “Participant” means a person who is selected or designated to receive benefits under this Plan
pursuant to the provisions hereof and who is at the time an officer or other key employee of the Company or any one or more of its Subsidiaries, or who has agreed to commence serving in any of such capacities within 90 days of the Date of Grant, and
also includes each Non-Employee Director who receives Shares or an award of Option Rights, Appreciation Rights, Restricted Stock, Restricted Stock Units or other awards under this Plan. 

 

	(ii)	 “Participant’s Representative” means (i) in the case of a deceased Participant, the
Participant’s executor or administrator or, if the deceased Participant’s estate is exempt from or not otherwise subject to administration, the person or persons to whom the Participant’s rights under any Option Rights have been
transferred by will or the laws of descent and distribution, and (ii) in the case of a disabled or incapacitated Participant, the Participant’s
attorney-in-fact or legal guardian. 

  

	(jj)	 “Performance Period” means, in respect of a Performance Share or Performance Unit, a period of time
established pursuant to Section 8 of this Plan within which the Management Objectives relating to such Performance Share or Performance Unit are to be achieved. 

 

	(kk)	 “Performance Share” means a bookkeeping entry that records the equivalent of one Share awarded
pursuant to Section 8 of this Plan. 

  

	(ll)	 “Performance Unit” means a bookkeeping entry that records a unit equivalent to $1.00 or such other
value as is determined by the Board or the Chief Executive Officer or his delegate or delegatees awarded pursuant to Section 8 of this Plan. 

  

	(mm)	 “Plan” means this STERIS plc 2006 Long-Term Incentive Plan (As Assumed, Amended and Restated
Effective March 28, 2019), as may be amended from time to time, in respect of periods from and after the Redomiciliation, and the Prior STERIS UK Plan or the Prior STERIS Corp. Plan, as applicable, each as amended from time to time, in respect
of periods prior to the Redomiciliation. 

  

	(nn)	 “Prior STERIS Corp. Plan” has the meaning set forth in the first paragraph of this Plan.

  

	(oo)	 “Prior STERIS UK Plan” has the meaning set forth in the second paragraph of this Plan.

  

	(pp)	 “Qualifying Retirement” has the meaning specified in Section 11(b)(iii) of this Plan.

  

	(qq)	 “Qualifying Retirement Eligible” means that a Participant has attained age 55 and has been in the
service of the Company and/or a Subsidiary for at least five consecutive years. Unless otherwise determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, the Participant will be deemed to have “been
in the service of the Company and/or a Subsidiary for at least five consecutive years” only if the Participant was in the service of the Company and/or one or more Subsidiaries, in the case of a Participant who is an Employee, throughout the
five year period ending on the Service Termination Date. 

  

	(rr)	 “Qualifying Service Termination” means the termination of a Participant’s service with the
Company and/or a Subsidiary when the Participant is Qualifying Service Termination Eligible; provided that the expiration date of the relevant award has not occurred and the Participant has not engaged in any Detrimental Activity.

  

	(ss)	 “Qualifying Service Termination Eligible” means that a Participant has been in the service of the
Company and/or a Subsidiary for at least twenty-five consecutive years. Unless otherwise determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, the Participant will be deemed to have “been in the
service of the Company and/or a Subsidiary for at least twenty-five consecutive years” only if the Participant was in the service of the Company and/or one or more Subsidiaries, in the case of a Participant who is an Employee, throughout the
twenty-five year period ending on the Service Termination Date. 

  

	(tt)	 “Redomiciliation” has the meaning set forth in the second paragraph of this Plan.

  

	(uu)	 “Restricted Stock” means Shares, including any Common Shares that were converted into STERIS UK
Ordinary Shares and any STERIS UK Ordinary Shares that were cancelled and replaced by Ordinary Shares, as described in the second paragraph of this Plan, granted or sold pursuant to Section 6 or Section 9 of this Plan as to which neither
the substantial risk of forfeiture nor the prohibition on transfers has expired. 

  

	(vv)	 “Restricted Stock Unit” means an award of the right to receive Shares, including any right to receive
Common Shares that was converted into a right to receive STERIS UK Ordinary Shares and any right to receive STERIS UK Ordinary Shares that was converted into a right to receive Ordinary Shares, or cash at the end of a specified period made pursuant
to Section 7 or Section 9 of this Plan. 

  
 5 

	(ww)	 “Restriction Period” means the period of time during which Restricted Stock Units are subject to
restrictions, as provided in Section 7 or Section 9 of this Plan. 

  

	(xx)	 “Scheme” has the meaning set forth in the second paragraph of this Plan. 

 

	(yy)	 “Service Termination Date” means, subject to the other terms of the Plan, (i) with respect to an
Employee, the first date on which, as of the end of the day, the Employee is no longer employed by the Company or any Subsidiary and (ii) with respect to a Director who is a Non-Employee Director, the
first date on which, as of the end of the day, the Non-Employee Director ceases to serve as a Director; provided, that, for the avoidance of doubt, the date on which the Combination was completed and
the date on which the Redomiciliation is completed shall not be, in either case, a Service Termination Date for any Non-Employee Director who, upon completion of the Combination, ceased to serve as a Director
of STERIS Corp. and immediately commenced to serve as a Director of STERIS UK, or who, upon completion of the Redomiciliation, ceases to serve as a Director of STERIS UK and immediately commences to serve as a Director of STERIS IE. References in
the Plan to a Participant’s “service” shall be deemed to be, with respect to an Employee, to the Employee’s employment with the Company or a Subsidiary, and with respect to a Director who is a
Non-Employee Director, to the Director’s service on the Board. 

  

	(zz)	 “Shares” means Ordinary Shares in respect of periods on and after the Redomiciliation and STERIS UK
Ordinary Shares or Common Shares, as applicable, in respect of periods prior to the Redomiciliation. 

  

	(aaa)	 “Spread” means the excess of the Market Value per Share on the date when an Option Right or
Appreciation Right is exercised over the Option Price or Base Price provided for in the related Option Right or Free-Standing Appreciation Right, respectively. 

 

	(bbb)	 “STERIS Corp.” has the meaning set forth in the first paragraph of this Plan. 

 

	(ccc)	 “STERIS IE” has the meaning set forth in the second paragraph of this Plan. 

 

	(ddd)	 “STERIS UK” has the meaning set forth in the first paragraph of this Plan. 

 

	(eee)	 “STERIS UK Ordinary Shares” means the ordinary shares, par value £0.10, of STERIS UK.

  

	(fff)	 “Subsidiary” means a corporation, company or other entity (i) at least 50 percent of whose
outstanding shares or securities (representing the right to vote for the election of directors or other managing authority) are, or (ii) which does not have outstanding shares or securities (as may be the case in a partnership, joint venture or
unincorporated association), but at least 50 percent of whose ownership interest representing the right generally to make decisions for such other entity is, now or hereafter, owned or controlled, directly or indirectly, by the Company except
that for purposes of determining whether any person may be a Participant for purposes of any grant of Incentive Stock Options, “Subsidiary” means any corporation in which at the time the Company owns or controls, directly or indirectly, at
least 50 percent of the total combined voting power represented by all classes of stock issued by such corporation. 

  

	(ggg)	 “Synergy” has the meaning set forth in the first paragraph of this Plan. 

 

	(hhh)	 “Tandem Appreciation Right” means an Appreciation Right granted pursuant to Section 5 or
Section 9 of this Plan that is granted in tandem with an Option Right. 

  

	(iii)	 “Voting Stock” means securities entitled to vote generally in the election of directors.

 3. Shares Available Under the Plan. 
  

	(a)	 Maximum Shares Available Under Plan. 

 

	 	(i)	 Subject to adjustment as provided in Section 13 of this Plan, the number of Shares that may be issued or
transferred on or after the Effective Date (A) upon the exercise of Option Rights or Appreciation Rights, (B) in payment of Restricted Stock and released from substantial risks of forfeiture thereof, (C) as Restricted Stock Units,
(D) in payment of Performance Shares or Performance Units that have been earned, (E) as awards contemplated by Section 10 of this Plan, or (F) in payment of dividend equivalents paid with respect to awards made under the Plan
will not exceed in the aggregate Twelve Million Two Hundred Thousand (12,200,000) Shares. In addition to the Shares authorized by the preceding sentence, to the extent any award under the Plan otherwise terminates without the issuance of some or all
of the Shares underlying the award to a Participant or if any option under the Plan terminates without having been exercised in full, the Shares underlying such award, to the extent of any such forfeiture or termination, shall be available for
future grant under the Plan and credited toward the Plan limit. Such shares may be shares of original issuance or treasury shares or a combination of the foregoing. 

  
 6 

	 	(ii)	 The total number of Shares available under the Plan as of a given date shall not be reduced by any Shares
relating to prior awards that have expired or have been forfeited or cancelled. Notwithstanding anything to the contrary contained herein: (A) the number of Shares tendered or otherwise used in payment of the Option Price of an Option Right
shall nonetheless reduce the aggregate plan limit described above; (B) the number of Shares withheld by the Company to satisfy the tax withholding obligation shall reduce the aggregate plan limit described above; and (C) the number of
Shares covered by an Appreciation Right, to the extent that it is exercised and settled in Shares, and whether or not shares are actually issued to the Participant upon exercise of the right, shall be considered issued or transferred pursuant to the
Plan. In the event that the Company repurchases Shares with Option Right proceeds, those Shares will not be added to the aggregate plan limit described above. 

 

	(b)	 Limits. Notwithstanding anything elsewhere in this Plan to the contrary, but subject as well to the
other limitations contained in this Section 3 and subject to adjustment as provided in Section 13 of this Plan: 

  

	 	(i)	 The aggregate number of Shares actually issued or transferred by the Company upon the exercise of Incentive
Stock Options (after taking into account forfeitures and cancellations) shall not exceed Two Million (2,000,000) Shares. 

  

	 	(ii)	 No Participant will be granted Option Rights or Appreciation Rights, in the aggregate, for more than One
Million (1,000,000) Shares during any calendar year. 

  

	 	(iii)	 No Participant will be granted Restricted Stock or Restricted Stock Units that specify Management Objectives,
Performance Shares, Performance Units or other awards under Section 10 of this Plan that specify Management Objectives, in the aggregate, for more than Five Hundred Thousand (500,000) Shares (or, in the case of Performance Units, the cash
equivalent thereof based on the Market Value per Share as of the Date of Grant) during any calendar year. 

 4. Option Rights. The
Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may, from time to time and upon such terms and conditions as it may determine, authorize the granting to Participants of options to purchase Shares. Each such grant
will be subject to all of the requirements contained in, and may contain such provisions as are authorized by, the following provisions: 
  

	(a)	 Each grant will specify the number of Shares to which it pertains subject to the limitations set forth in
Section 3 of this Plan. 

  

	(b)	 Each grant will specify an Option Price per share, which may not be less than the Market Value per Share on the
Date of Grant. 

  

	(c)	 Each grant will specify whether the Option Price will be payable (i) in cash or by check acceptable to the
Company or by wire transfer of immediately available funds, (ii) by the actual or constructive transfer to the Company of Shares owned by the Optionee having a value at the time of exercise equal to the total Option Price, (iii) by a
combination of such methods of payment, or (iv) by such other methods as may be approved by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable. 

 

	(d)	 To the extent permitted by law, any grant may provide for deferred payment of the Option Price from the
proceeds of sale through a bank or broker on a date satisfactory to the Company of some or all of the shares to which such exercise relates. 

  

	(e)	 Successive grants may be made to the same Participant whether or not any Option Rights previously granted to
such Participant remain unexercised. 

  

	(f)	 Each grant will specify the period or periods of continuous service by the Optionee with the Company or any
Subsidiary that is necessary before the Option Rights or installments thereof will become exercisable. A grant of Option Rights may provide for the earlier exercise of such Option Rights in the event of the retirement, death or Disability (as
defined in Section 23(h) of this Plan) of a Participant. Unless otherwise provided in the relevant Evidence of Award, each grant of Option Rights shall be subject to Section 23 hereof. 

 

	(g)	 Any grant of Option Rights may specify Management Objectives that must be achieved as a condition to the
exercise of such rights. 

  
 7 

	(h)	 Option Rights granted under this Plan may be (i) options, including, without limitation, Incentive Stock
Options, that are intended to qualify under particular provisions of the Code, (ii) options that are not intended so to qualify, or (iii) combinations of the foregoing. Incentive Stock Options may only be granted to Participants who meet
the definition of “employees” under Section 3401(c) of the Code. 

  

	(i)	 The exercise of an Option Right will result in the cancellation on a share-for-share basis of any Tandem Appreciation Right authorized under Section 5 of this Plan that was granted therewith. 

 

	(j)	 Except as otherwise provided herein or in an Evidence of Award, no Option Right will be exercisable more than
10 years from the Date of Grant. 

  

	(k)	 Each grant of Option Rights will be evidenced by an Evidence of Award. Each Evidence of Award shall be subject
to this Plan and shall contain such terms and provisions, consistent with this Plan, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may approve. 

5. Appreciation Rights. 
  

	(a)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may also authorize the
granting (i) to any Optionee, of Tandem Appreciation Rights in respect of Option Rights granted hereunder, and (ii) to any Participant, of Free-Standing Appreciation Rights. A Tandem Appreciation Right will be a right of the Optionee,
exercisable by surrender of the related Option Right, to receive from the Company an amount determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, which will be expressed as a percentage of the Spread
(not exceeding 100 percent) at the time of exercise. Tandem Appreciation Rights may be granted at any time prior to the exercise or termination of the related Option Rights; provided, however, that a Tandem Appreciation Right awarded in
relation to an Incentive Stock Option must be granted concurrently with such Incentive Stock Option. A Free-Standing Appreciation Right will be a right of the Participant to receive from the Company an amount determined by the Board or the Chief
Executive Officer or his delegatee or delegatees, as applicable, which will be expressed as a percentage of the Spread (not exceeding 100 percent) at the time of exercise. 

 

	(b)	 Each grant of Appreciation Rights will be subject to all of the requirements contained in, and may contain such
provisions as are authorized by, the following provisions: 

  

	 	(i)	 Any grant may specify that the amount payable on exercise of an Appreciation Right may be paid by the Company
in cash, in Shares or in any combination thereof and may either grant to the Participant or retain in the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, the right to elect among those alternatives.

  

	 	(ii)	 Any grant may specify that the amount payable on exercise of an Appreciation Right may not exceed a maximum
specified by the Board at the Date of Grant. 

  

	 	(iii)	 Any grant may specify waiting periods before exercise and permissible exercise dates or periods.

  

	 	(iv)	 Any grant may specify that such Appreciation Right may be exercised only in the event of, or earlier in the
event of, the retirement, death or Disability of a Participant. Unless otherwise provided in the relevant Evidence of Award, each grant of Appreciation Rights shall be subject to Section 23 hereof. 

 

	 	(v)	 Any grant of Appreciation Rights may specify Management Objectives that must be achieved as a condition of the
exercise of such Appreciation Rights. 

  

	 	(vi)	 Each grant of Appreciation Rights will be evidenced by an Evidence of Award, which Evidence of Award will
describe such Appreciation Rights, identify the related Option Rights (if applicable), and contain such other terms and provisions, consistent with this Plan, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable,
may approve. 

  

	(c)	 Any grant of Tandem Appreciation Rights will provide that such Tandem Appreciation Rights may be exercised only
at a time when the related Option Right is also exercisable and at a time when the Spread is positive, and by surrender of the related Option Right for cancellation. Successive grants of Tandem Appreciation Rights may be made to the same Participant
regardless of whether any Tandem Appreciation Rights previously granted to the Participant remain unexercised. 

  

	(d)	 Regarding Free-Standing Appreciation Rights only: 

 

	 	(i)	 Each grant will specify in respect of each Free-Standing Appreciation Right a Base Price, which may not be less
than the Market Value per Share on the Date of Grant; 

  
 8 

	 	(ii)	 Successive grants may be made to the same Participant regardless of whether any Free-Standing Appreciation
Rights previously granted to the Participant remain unexercised; and 

  

	 	(iii)	 Except as otherwise provided herein or in an Evidence of Award, no Free-Standing Appreciation Right granted
under this Plan may be exercised more than 10 years from the Date of Grant. 

 6. Restricted Stock. The Board or the Chief
Executive Officer or his delegatee or delegatees, as applicable, may also authorize the grant or sale of Restricted Stock to Participants. Each such grant or sale will be subject to all of the requirements contained in, and may contain such
provisions as are authorized by, the following provisions and the other provisions of the Plan: 
  

	(a)	 Each such grant or sale will constitute an immediate transfer of the ownership of Shares to the Participant in
consideration of the performance of services, entitling such Participant to voting, dividend and other ownership rights (subject to such restrictions as are set out in the Evidence of Award), but subject to the substantial risk of forfeiture and
restrictions on transfer hereinafter referred to. 

  

	(b)	 Each such grant or sale may be made without additional consideration or in consideration of a payment by such
Participant that is less than the Market Value per Share at the Date of Grant. 

  

	(c)	 Each such grant or sale will provide that the Restricted Stock covered by such grant or sale that vests upon
the passage of time will be subject to a “substantial risk of forfeiture” within the meaning of Section 83 of the Code for a period to be determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as
applicable, at the Date of Grant and may provide for the earlier lapse of such substantial risk of forfeiture as provided in Section 6(e) below or in the event of the retirement, death or Disability of a Participant or as otherwise provided
herein. Unless otherwise provided in the relevant Evidence of Award, all substantial risks of forfeiture or restrictions on transfer applicable to any grant or sale of Restricted Stock shall be subject to Section 23 hereof.

  

	(d)	 Each such grant or sale will provide that during the period for which such substantial risk of forfeiture is to
continue, the transferability of the Restricted Stock will be prohibited or restricted in the manner and to the extent prescribed by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, at the Date of Grant (which
restrictions may include, without limitation, rights of repurchase or first refusal in the Company or provisions subjecting the Restricted Stock to a continuing substantial risk of forfeiture in the hands of any transferee). 

 

	(e)	 Any grant of Restricted Stock may specify Management Objectives that, if achieved, will result in termination
or early termination of the restrictions applicable to such Restricted Stock. Each grant may specify in respect of such Management Objectives a minimum acceptable level of achievement and may set forth a formula for determining the number of shares
of Restricted Stock on which restrictions will terminate if performance is below, at or above the minimum or threshold level or levels, or is at or above the target level or levels, but falls short of maximum achievement of the specified Management
Objectives. 

  

	(f)	 Any such grant or sale of Restricted Stock may require that any or all dividends or other distributions paid
thereon during the period of such restrictions be automatically deferred and reinvested in additional shares of Restricted Stock, which may be subject to the same restrictions as the underlying award. 

 

	(g)	 Each grant or sale of Restricted Stock will be evidenced by an Evidence of Award and will contain such terms
and provisions, consistent with this Plan, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may approve. Unless otherwise directed by the Board or the Chief Executive Officer or his delegatee or delegatees,
as applicable, all certificates representing shares of Restricted Stock will be held in custody by the Company until all restrictions thereon will have lapsed, together with a stock power or powers executed by the Participant in whose name such
certificates are registered, endorsed in blank and covering such Shares. 

 7. Restricted Stock Units. The Board or the Chief
Executive Officer or his delegatee or delegatees, as applicable, may also authorize the granting or sale of Restricted Stock Units to Participants. Each such grant or sale will be subject to all of the requirements contained in, and may contain such
provisions as are authorized by, the following provisions and the other provisions of the Plan: 
  

	(a)	 Each such grant or sale will constitute the agreement by the Company to deliver Shares or cash to the
Participant in the future in consideration of the performance of services, but subject to the fulfillment of such conditions (which may include the achievement of Management Objectives) during the Restriction Period as

  
 9 

	 	
the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may specify. Each grant that specifies Management Objectives may further specify in respect of such
Management Objectives a minimum acceptable level of achievement and may set forth a formula for determining the number of shares of Restricted Stock Units on which restrictions will terminate if performance is at or above the minimum level, but
falls short of full achievement of the specified Management Objectives. In addition, any grant of such Restricted Stock Units will further specify that, before the termination or early termination of restrictions applicable to such Restricted Stock
Units, the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, must determine that the Management Objectives have been satisfied. 

  

	(b)	 Each such grant or sale may be made without additional consideration or in consideration of a payment by such
Participant that is less than the Market Value per Share at the Date of Grant. 

  

	(c)	 If the Restriction Period lapses only by the passage of time, each such grant or sale will be subject to a
Restriction Period, as determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, at the Date of Grant, and may provide for the earlier lapse or other modification of such Restriction Period in the event of
the retirement, death or Disability of a Participant or as otherwise provided herein. Unless otherwise provided on the relevant Evidence of Award, the Restriction Period applicable to any grant of Restricted Stock Units shall be subject to
Section 23 hereof. 

  

	(d)	 During the Restriction Period, the Participant will have no right to transfer any rights under his or her award
and will have no rights of ownership in the Restricted Stock Units and will have no right to vote them, but the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may at the Date of Grant, authorize the payment of
dividend equivalents on such Restricted Stock Units on either a current or deferred or contingent basis, either in cash or in additional Shares. 

  

	(e)	 Each grant or sale will specify the time and manner of payment of the Restricted Stock Units that have been
earned. Any grant or sale may specify that the amount payable with respect thereto may be paid by the Company in cash, in Shares or in any combination thereof and may either grant to the Participant or retain in the Board or the Chief Executive
Officer or his delegatee or delegatees, as applicable, the right to elect among those alternatives. 

  

	(f)	 Each grant or sale of Restricted Stock Units will be evidenced by an Evidence of Award and will contain such
terms and provisions, consistent with this Plan, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may approve. 

8. Performance Shares and Performance Units. The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may also authorize
the granting of Performance Shares and Performance Units that will become payable to a Participant upon achievement of specified Management Objectives during the Performance Period. Each such grant will be subject to all of the requirements
contained in, and may contain such provisions as are authorized by, the following provisions: 
  

	(a)	 Each grant will specify the number of Performance Shares or Performance Units to which it pertains, which
number may be subject to adjustment to reflect changes in compensation or other factors. 

  

	(b)	 The Performance Period with respect to each Performance Share or Performance Unit will be such period of time
as will be determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, at the time of grant, which may be subject to earlier lapse or other modification in the event of the retirement, death or Disability of
a Participant. Unless otherwise provided in the relevant Evidence of Award, the Performance Period applicable to any grant of Performance Shares or Performance Units shall lapse and terminate, and the Management Objectives applicable thereto shall
be treated as having been achieved, upon a Change in Control. 

  

	(c)	 Any grant of Performance Shares or Performance Units will specify Management Objectives which, if achieved,
will result in payment or early payment of the award, and each grant may specify in respect of such specified Management Objectives a level or levels of achievement and will set forth a formula for determining the number of Performance Shares or
Performance Units that will be earned if performance is at or above the minimum level or levels, but falls short of full achievement of the specified Management Objectives. The grant of Performance Shares or Performance Units will specify that,
before the Performance Shares or Performance Units will be earned and paid, the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, must determine that the Management Objectives have been satisfied.

  
 10 

	(d)	 Each grant will specify the time and manner of payment of Performance Shares or Performance Units that have
been earned. Any grant may specify that the amount payable with respect thereto may be paid by the Company in cash, in Shares or in any combination thereof and may either grant to the Participant or retain in the Board or the Chief Executive Officer
or his delegatee or delegatees, as applicable, the right to elect among those alternatives. 

  

	(e)	 Any grant of Performance Shares may specify that the amount payable with respect thereto may not exceed a
maximum specified by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, at the Date of Grant. Any grant of Performance Units may specify that the amount payable or the number of Shares issued with respect thereto
may not exceed maximums specified by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, at the Date of Grant. 

  

	(f)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may at the Date of
Grant of Performance Shares, provide for the payment of dividend equivalents to the holder thereof on a deferred or contingent basis, either in cash or in additional Shares; provided, however, no dividend equivalents will be payable in
respect of Performance Shares prior to such time, if any, as the Performance Shares are earned or become payable. 

  

	(g)	 Each grant of Performance Shares or Performance Units will be evidenced by an Evidence of Award and will
contain such other terms and provisions, consistent with this Plan, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may approve. 

9. Awards to Non-Employee Directors. The Board may, from time to time and upon such terms and conditions as it
may determine, authorize the granting to Non-Employee Directors of Option Rights, Appreciation Rights or other awards contemplated by Section 10 of this Plan and may also authorize the grant or sale of
Shares, Restricted Stock or Restricted Stock Units to Non-Employee Directors. Each grant of an award to a Non-Employee Director will be upon such terms and conditions as
approved by the Board and will be evidenced by an Evidence of Award in such form as will be approved by the Board. Each grant will specify in the case of an Option Right an Option Price per share, and in the case of a Free-Standing Appreciation
Right, a Base Price per share, which will not be less than the Market Value per Share on the Date of Grant. Except as otherwise provided herein or in the applicable Evidence of Award, each Option Right and Free-Standing Appreciation Right granted
under the Plan to a Non-Employee Director will expire not more than 10 years from the Date of Grant and will be subject to earlier termination as hereinafter provided. If a
Non-Employee Director subsequently becomes an Employee while remaining a member of the Board, any award held under this Plan by such individual at the time of such commencement of employment will not be
affected thereby. Subject to Board approval, if an Employee who is a member of the Board ceases to be an Employee while remaining a member of the Board, any award held under this Plan by such individual at the time of such cessation of employment
shall not be affected thereby, and such cessation of employment shall not cause such Employee to have a Service Termination Date. Non-Employee Directors, pursuant to this Section 9, may be awarded, or may
be permitted to elect to receive, pursuant to procedures established by the Board, all or any portion of their annual retainer, meeting fees, chairman and committee chair fees or other fees in grants of awards pursuant to the preceding provisions or
in Shares in lieu of cash. 
 10. Other Awards. 
  

	(a)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may, subject to
limitations under applicable law, grant to any Participant such other awards that may be denominated or payable in, valued in whole or in part by reference to, or otherwise based on, or related to, Shares or factors that may influence the value of
such shares, including, without limitation, convertible or exchangeable debt securities, other rights convertible or exchangeable into Shares, purchase rights for Shares, awards with value and payment contingent upon performance of the Company or
specified Subsidiaries, affiliates or other business units thereof or any other factors designated by the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, and awards valued by reference to the book value of Shares
or the value of securities of, or the performance of specified Subsidiaries or affiliates or other business units of the Company. The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, shall determine the terms and
conditions of such awards. Shares delivered pursuant to an award in the nature of a purchase right granted under this Section 10 shall be purchased for such consideration, paid for at such time, by such methods, and in such forms, including,
without limitation, cash, Shares, other awards, notes or other property, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, shall determine. 

  
 11 

	(b)	 Cash awards, as an element of or supplement to any other award granted under this Plan, may also be granted
pursuant to this Section 10 of this Plan. 

  

	(c)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may grant Shares as a
bonus, or may grant other awards in lieu of obligations of the Company or a Subsidiary to pay cash or deliver other property under this Plan or under other plans or compensatory arrangements, subject to such terms as shall be determined by the Board
or the Chief Executive Officer or his delegatee or delegatees, as applicable. 

 11. Termination of Service. After a
Participant’s Service Termination Date, unless otherwise provided in the relevant Evidence of Award, the rules set forth in this Section 11 shall apply. All factual determinations with respect to the termination of a Participant’s
service that may be relevant under this Section 11 shall be made by the Board in its sole discretion or by such other person as may be authorized to make such determination pursuant to the provisions hereof, or by the person or persons to whom
such authority has been delegated pursuant to the provisions hereof, in his, her or their sole discretion. 
  

	(a)	 Termination Other Than Upon Qualifying Retirement, Death or Disability or for Cause. Upon any
termination of a Participant’s service for any reason other than the Participant’s Qualifying Retirement, Disability, or death or, in the case of Participants who are Employees, other than for Cause: 

 

	 	(i)	 Unless otherwise provided in the relevant Evidence of Award, the Participant shall have the right during the
period ending three months after the Service Termination Date, but not later than the Option Expiration Date or Appreciation Right Expiration Date, as applicable, to exercise any Option Rights and Appreciation Rights that were outstanding on the
Service Termination Date, if and to the same extent as those Option Rights and Appreciation Rights were exercisable by the Participant on the Service Termination Date; 

 

	 	(ii)	 Unless otherwise provided in the relevant Evidence of Award, in the case of any Restricted Stock for which the
Participant paid an Acquisition Price, the Participant shall offer for resale at the Acquisition Price to the Company each Share of Restricted Stock held by the Participant at the Service Termination Date with respect to which, as of that date, any
restrictions, conditions, or contingencies have not lapsed; and 

  

	 	(iii)	 Unless otherwise provided in the relevant Evidence of Award, the Participant shall forfeit each (A) Share
of Restricted Stock for which the Participant did not pay an Acquisition Price, (B) Restricted Stock Unit, (C) Performance Share, (D) Performance Unit, and/or (E) other award granted pursuant to Section 10 hereof, in each
case with respect to which, as of the Participant’s Service Termination Date, any restrictions, conditions, or contingencies have not lapsed. 

  

	(b)	 Qualifying Retirement. Upon a Participant’s Qualifying Retirement (as defined below) or Qualifying
Service Termination: 

  

	 	(i)	 Unless otherwise provided in the relevant Evidence of Award and so long as the Participant remains in
“Good Standing” (as defined below): 

  

	 	(A)	 The Participant will be entitled to exercise vested Option Rights and Appreciation Rights granted under the
relevant Evidence of Award from time to time on any date during the period (the “Extended Exercise Period”) that begins on the date of the Participant’s retirement (if applicable) or other termination of service with the Company
and/or a Subsidiary and ends on the expiration date of the relevant award; 

  

	 	(B)	 If, at any time during the Extended Exercise Period, the Participant fails to remain in Good Standing, any
Option Rights and Appreciation Rights granted under the relevant Evidence of Award that are then outstanding and held by the Participant shall be forfeited and of no force or effect; and 

 

	 	(C)	 If the Participant dies during the Extended Exercise Period and while in Good Standing, vested Option Rights
and Appreciation Rights granted under the Evidence of Award will thereafter be exercisable, to the extent exercisable by the Participant on the date of his death, at the same times (for so long and only so long after the Participant’s death) as
if the Participant had continued in the service of the Company through the date of the Participant’s death. 

  

	 	(ii)	 For the purposes of this Plan, a Participant will cease to remain in “Good Standing” during his or
her Extended Exercise Period if he or she engages or has engaged in any Detrimental Activity or commits or 

  
 12 

	 	
has committed a material violation of any applicable provision of any Company policy or of any Evidence of Award or other agreement with the Company or a Subsidiary or if, at any time during the
Extended Exercise Period, he or she otherwise acts in a manner detrimental to the interests of the Company or any of its Subsidiaries, including but not limited to, in the case of a Participant who is a
Non-Employee Director, directly or indirectly materially competing with the Company or any of its Subsidiaries. 

  

	 	(iii)	 For the purposes of this Plan, “Qualifying Retirement” means that a Participant terminates service
with the Company and/or a Subsidiary (A) with the consent of or under guidelines approved by the Board, or the Chief Executive Officer or his delegatee or delegatees, if applicable pursuant to Section 12(d) of this Plan, (B) without
having engaged in any Detrimental Activity, (C) before the expiration date of the relevant award, and (D) after having become Qualifying Retirement Eligible. 

 

	 	(iv)	 Unless otherwise provided in the applicable Evidence of Award, the provisions of this Section 11(b) shall
apply only to Plan awards with a Date of Grant on or after July 28, 2011. Plan awards with a Date of Grant prior to such date shall be governed by the provisions of Section 11(b) of the Plan as in effect prior to such date, as modified by
an applicable Evidence of Award. 

  

	 	(v)	 Notwithstanding anything to the contrary contained herein or in the applicable Evidence of Award, for the
avoidance of doubt, the provisions of Section 11(b)(i)(A) shall not apply in respect of a Participant’s Qualifying Retirement to any Option Right or Appreciation Right granted to any Participant if, at the time of the grant thereof, the
application of such provisions would violate applicable law because of the age requirement included in the Qualifying Retirement Eligible definition. 

  

	(c)	 Termination Due to Disability. Upon any termination of a Participant’s service due to Disability:

  

	 	(i)	 Unless otherwise provided in the relevant Evidence of Award, the Participant, or the Participant’s
Representative, shall have the right (1) to exercise, from time to time during the period ending one year after the Service Termination Date, but not later than the Option Expiration Date or Appreciation Right Expiration Date, as applicable,
any Nonqualified Stock Options and Appreciation Rights that were outstanding on the Service Termination Date, if and to the same extent those Option Rights and Appreciation Rights were exercisable by the Participant on the Service Termination Date,
and (2) to exercise, from time to time during the period ending one year after the Service Termination Date, but not later than the Option Expiration Date, any Incentive Stock Options that were outstanding on the Service Termination Date, if
and to the same extent as those Option Rights were exercisable by the Participant on the Service Termination Date (even though exercise of the Incentive Stock Option more than three months after the Service Termination Date may cause the Option
Right to fail to qualify for Incentive Stock Option treatment under the Code); 

  

	 	(ii)	 Unless otherwise provided in the relevant Evidence of Award, in the case of any Restricted Stock for which the
Participant paid an Acquisition Price, the Participant, or the Participant’s Representative, shall offer for resale at the Acquisition Price to the Company each Share of Restricted Stock held by the Participant at the Service Termination Date
with respect to which, as of that date, any restrictions, conditions, or contingencies have not lapsed; and 

  

	 	(iii)	 Unless otherwise provided in the relevant Evidence of Award, the Participant shall forfeit each (A) Share
of Restricted Stock for which the Participant did not pay an Acquisition Price, (B) Restricted Stock Unit, (C) Performance Share, (D) Performance Unit, and/or (E) other award granted pursuant to Section 10 hereof, in each
case with respect to which, as of the Participant’s Service Termination Date, any restrictions, conditions, or contingencies have not lapsed. 

  

	(d)	 Death of an Employee. Upon the death of a Participant while in the service of the Company or any
Subsidiary or within any of the periods referred to in any of Sections 11(a), 11(b), or 11(c): 

  

	 	(i)	 Unless otherwise provided in the relevant Evidence of Award (in which a different period of extension of the
Option Expiration Date or Appreciation Right Expiration Date, as applicable, in the event of the death of the Participant may be specified), if the Option Expiration Date or Appreciation Right Expiration Date, as applicable, of any Nonqualified
Stock Option or Appreciation Right that had not expired before the Participant’s death would otherwise expire before the first anniversary of the Participant’s death, that Option Expiration Date or Appreciation Right Expiration Date, as
applicable, shall automatically be extended to the first anniversary of the Participant’s death; 

  
 13 

	 	(ii)	 Unless otherwise provided in the relevant Evidence of Award, any Option Rights and Appreciation Rights that are
outstanding on the date of the Participant’s death shall become immediately exercisable in full and the Participant’s Representative shall have the right to exercise any or all of those Option Rights and Appreciation Rights in accordance
with Section 4(f) (as to any Option Rights) or Section 5(b) (as to any Appreciation Rights), from time to time during the period ending on the first anniversary of the Participant’s death; 

 

	 	(iii)	 Unless otherwise provided in the relevant Evidence of Award, all Restricted Stock or Restricted Stock Units
held by a Participant who dies while employed by the Company or a Subsidiary shall immediately become fully vested and nonforfeitable; 

  

	 	(iv)	 Unless otherwise provided in the relevant Evidence of Award, the restrictions, conditions, or contingencies on
any (A) Performance Shares, (B) Performance Units, and/or (C) any other award granted pursuant to Section 10 hereof held by the Participant at the date of death shall be modified in such manner as the Board or the Chief Executive
Officer or his delegatee or delegatees, as applicable, may specify to give the Participant’s Representative the benefit of those awards through that date. 

 

	(e)	 Termination for Cause. Upon any termination of service for Cause of a Participant who is an Employee,
and unless otherwise provided in the relevant Evidence of Award: 

  

	 	(i)	 All of the Participant’s rights with respect to unexercised Option Rights and Appreciation Rights shall
expire immediately before the Service Termination Date; 

  

	 	(ii)	 In the case of any Restricted Stock for which the Participant paid an Acquisition Price, the Participant shall
offer for resale at the Acquisition Price to the Company all Restricted Stock held by the Participant at the Service Termination Date with respect to which, as of that date, any restrictions, conditions, or contingencies have not lapsed; and

  

	 	(iii)	 The Participant shall forfeit all (A) Shares of Restricted Stock for which the Participant did not pay an
Acquisition Price, (B) Restricted Stock Units, (C) Performance Shares, (D) Performance Units and (E) any other awards granted pursuant to Section 10 hereof, in each case with respect to which, as of the Participant’s
Service Termination Date, any restrictions, conditions, or contingencies have not lapsed. 

 For the avoidance of doubt, the provisions of
this Section 11(e) do not apply to any Participant who was a Non-Employee Director immediately prior to his or her Service Termination Date. 

12. Administration of the Plan. 
  

	(a)	 Except as set forth in Section 12(d) of this Plan, this Plan will be administered by the Board of
Directors of the Company, which may from time to time delegate all or any part of its authority under this Plan to the Compensation Committee of the Board of Directors of the Company or any other Committee of the Board of Directors of the Company
(or a subcommittee thereof), as constituted from time to time. 

  

	(b)	 The interpretation and construction by the Board, or the Chief Executive Officer or his delegatee or
delegatees, if applicable, of any provision of this Plan or of any agreement, notification or document evidencing the grant of Option Rights, Appreciation Rights, Restricted Stock, Restricted Stock Units, Performance Shares, Performance Units or
other awards pursuant to Section 10 of this Plan and any determination by the Board, or the Chief Executive Officer or his delegatee or delegatees, if applicable, pursuant to any provision of this Plan or of any such agreement, notification or
document, will be final and conclusive. 

  

	(c)	 The Board may delegate to one or more of its members or to one or more officers of the Company, or to one or
more agents or advisors, such administrative duties or powers as it may deem advisable, and the Board or any person to whom duties or powers have been delegated as aforesaid, may employ one or more persons to render advice with respect to any
responsibility the Board or such person may have under the Plan. The Board may, by resolution, authorize the Chief Executive Officer (or his delegatee or delegatees) to do one or both of the following on the same basis as the Board:
(i) designate employees to be recipients of awards under this Plan; and (ii) determine the size of any such awards; provided, however, that (A) the Board shall not so delegate such responsibilities for awards granted to an
individual who is a Director or an “officer” (as defined in Rule 16a-1(f) promulgated under the Exchange Act, or in any successor to such rule) of the Company; and (B) the resolution providing
for such authorization sets forth the total number of Shares the Chief Executive Officer (or his delegatee or delegatees) may grant. The Chief Executive Officer (or his delegatee or delegatees) shall report periodically to the Board regarding the
nature and scope of the awards granted pursuant to the authority delegated. 

  
 14 

	(d)	 Notwithstanding anything to the contrary, other than Section 12(c) hereof to which this Section 12(d)
is subject, all interpretations, conclusions or determinations with respect to any provisions of this Plan or of any related agreement, notification or document, and all factual determinations, including but not limited to determinations made
pursuant to Sections 11 and 15 of this Plan and determinations regarding “Cause” and “Detrimental Activity” and “Good Standing” and “Qualifying Retirement” (i) shall be made by the Board, with respect to
the Chief Executive Officer, all other “officers” (as defined in Rule 16a-1(f) promulgated under the Exchange Act, or in any successor to such rule) and all Directors; provided, however, that
any Director whose specific rights under the Plan are the subject of any interpretation, conclusion or determination by the Board shall not take part in or contribute to such interpretation, conclusion or determination, and (ii) with respect to
all Participants other than the individuals described in clause (i) of this sentence, shall be made by the Board or by the Chief Executive Officer or his delegatee or delegatees; provided, however, that in the event of any conflict
between a determination made by the Board and a determination made by the Chief Executive Officer or his delegatee or delegatees, the determination of the Board shall control. 

13. Adjustments. The Board shall make or provide for such adjustments in the numbers of Ordinary Shares covered by outstanding Option Rights,
Appreciation Rights, Restricted Stock Units, Performance Shares and Performance Units granted hereunder and, if applicable, in the number of Ordinary Shares covered by other awards granted pursuant to Section 10 hereof, in the Option Price and
Base Price provided in outstanding Option Rights and Appreciation Rights, and in the kind of shares covered thereby, as is equitably required to prevent dilution or enlargement of the rights of Participants or Optionees that otherwise would result
from (a) any stock dividend, stock split, combination of shares, recapitalization or other change in the capital structure of the Company, or (b) any merger, consolidation, spin-off, split- off, spin-out, split-up, reorganization, partial or complete liquidation or other distribution of assets, issuance of rights or warrants to purchase securities, or (c) any
other corporate transaction or event having an effect similar to any of the foregoing. The Board shall also make or provide for such adjustments in the numbers of Shares specified in Section 3 of this Plan as is appropriate to reflect any
transaction or event described in the preceding sentence. Any such adjustment to the number specified in Section 3(b)(i) shall be made in such manner as to not cause any option intended to qualify as an Incentive Stock Option to fail so to
qualify. Moreover, in the event of any such transaction or event or in the event of a Change in Control, the Board, in its discretion, may provide in substitution for any or all outstanding awards under this Plan such alternative consideration
(including cash), if any, as it may determine to be equitable in the circumstances and may require in connection therewith the surrender of all awards so replaced. In addition, for each Option Right or Appreciation Right with an Option Price or Base
Price greater than the consideration offered in connection with any such transaction or event or Change in Control, the Board may in its discretion elect to cancel such Option Right or Appreciation Right without any payment to the person holding
such Option Right or Appreciation Right. 
 14. Change in Control. For purposes of this Plan, except as may be otherwise prescribed by the Board or
the Chief Executive Officer or his delegatee or delegatees, as applicable, in an Evidence of Award made under this Plan, a “Change in Control” shall be deemed to have occurred upon the occurrence of any of the following events: 

 

	(a)	 any individual, entity or group (within the meaning of Section 13(d)(3) or 14(d)(2) of the Exchange Act)
(a “Person”) is or becomes the beneficial owner (within the meaning of Rule 13d-3 promulgated under the Exchange Act) of 25% or more of the combined voting power of the then-outstanding Voting Stock
of the Company; provided, however, that: 

  

	 	(i)	 for purposes of this Section 14(a), the following acquisitions shall not constitute a Change in Control:
(A) any acquisition of Voting Stock of the Company directly from the Company that is approved by a majority of the Incumbent Directors, (B) any acquisition of Voting Stock of the Company by the Company or any Subsidiary, (C) any
acquisition of Voting Stock of the Company by the trustee or other fiduciary holding securities under any employee benefit plan (or related trust) sponsored or maintained by the Company or any Subsidiary, and (D) any acquisition of Voting Stock
of the Company by any Person pursuant to a Business Transaction (as defined below) that complies with clauses (i), (ii) and (iii) of Section 14(c) below; 

 

	 	(ii)	 if any Person is or becomes the beneficial owner of 25% or more of combined voting power of the
then-outstanding Voting Stock of the Company as a result of a transaction described in clause (A) of Section 14(a)(i) above and such Person thereafter becomes the beneficial owner of any additional shares

  
 15 

	 	
of Voting Stock of the Company representing 1% or more of the then-outstanding Voting Stock of the Company, other than in an acquisition directly from the Company that is approved by a majority
of the Incumbent Directors or other than as a result of a stock dividend, stock split or similar transaction effected by the Company in which all holders of Voting Stock are treated equally, such subsequent acquisition shall be treated as a Change
in Control; 

  

	 	(iii)	 a Change in Control will not be deemed to have occurred if a Person is or becomes the beneficial owner of 25%
or more of the Voting Stock of the Company as a result of a reduction in the number of shares of Voting Stock of the Company outstanding pursuant to a transaction or series of transactions that is approved by a majority of the Incumbent Directors
unless and until such Person thereafter becomes the beneficial owner of any additional shares of Voting Stock of the Company representing 1% or more of the then-outstanding Voting Stock of the Company, other than as a result of a stock dividend,
stock split or similar transaction effected by the Company in which all holders of Voting Stock are treated equally; and 

  

	 	(iv)	 if at least a majority of the Incumbent Directors determine in good faith that a Person has acquired beneficial
ownership of 25% or more of the Voting Stock of the Company inadvertently, and such Person divests as promptly as practicable but no later than the date, if any, set by the Incumbent Board a sufficient number of shares so that such Person
beneficially owns less than 25% of the Voting Stock of the Company, then no Change in Control shall have occurred as a result of such Person’s acquisition; or 

 

	(b)	 a majority of the Board ceases to be comprised of Incumbent Directors; or 

 

	(c)	 the consummation of a reorganization, merger or consolidation, or sale or other disposition of all or
substantially all of the assets of the Company or the acquisition of the stock or assets of another corporation, or other transaction (each, a “Business Transaction”), unless, in each case, immediately following such Business Transaction
(i) the Voting Stock of the Company outstanding immediately prior to such Business Transaction continues to represent (either by remaining outstanding or by being converted into Voting Stock of the surviving entity or any parent thereof), more
than 50% of the combined voting power of the then outstanding shares of Voting Stock of the entity resulting from such Business Transaction (including, without limitation, an entity which as a result of such transaction owns the Company or all or
substantially all of the Company’s assets either directly or through one or more subsidiaries), (ii) no Person (other than the Company, such entity resulting from such Business Transaction, or any employee benefit plan (or related trust)
sponsored or maintained by the Company, any Subsidiary or such entity resulting from such Business Transaction) beneficially owns, directly or indirectly, 25% or more of the combined voting power of the then outstanding shares of Voting Stock of the
entity resulting from such Business Transaction, and (iii) at least a majority of the members of the Board of Directors of the entity resulting from such Business Transaction were Incumbent Directors at the time of the execution of the initial
agreement or of the action of the Board providing for such Business Transaction; or 

  

	(d)	 approval by the shareholders of the Company of a complete liquidation or dissolution of the Company, except
pursuant to a Business Transaction that complies with clauses (i), (ii) and (iii) of Section 14(c). 

 For the avoidance of
doubt, the amendments to the Prior STERIS Plan effected at or around the time of the Combination were not intended to cause the Combination, or the transactions that occurred in connection with the Combination, and the amendments to the Prior STERIS
UK Plan effected hereby are not intended to cause the Redomiciliation, or the transactions contemplated in conjunction with the Redomiciliation, to have constituted, or to constitute, a “Change in Control” for purposes of the Plan and such
amendments shall continue to be, and shall hereafter be, construed in accordance with such intent. 
 15. Detrimental Activity. Any Evidence of Award
may provide that if a Participant, either during service with the Company or a Subsidiary or within a period of two years (or such other period as may be specified in the Evidence of Award) after termination of such service, shall engage in any
Detrimental Activity, and the Board, or the Chief Executive Officer or his delegatee or delegatees, if applicable, shall so find, forthwith upon notice of such finding, the Participant shall: 

 

	(a)	 Forfeit any award granted under the Plan then held by the Participant; 

 

	(b)	 In the sole and complete discretion of the Company, return to the Company, in exchange for payment by the
Company of any amount actually paid therefor by the Participant, all Shares that the Participant has not disposed of that were offered, acquired or paid out pursuant to or in connection with this Plan within a period of two years (or such longer
period as may be specified in an Evidence of Award) prior to the date of the commencement of such Detrimental Activity or during or after the Detrimental Activity; and 

  
 16 

	(c)	 In the sole and complete discretion of the Company, with respect to any Shares so acquired or paid out that the
Participant has disposed of within a period of two years (or such longer period as may be specified in an Evidence of Award) prior to the date of the commencement of such Detrimental Activity or during or after such Detrimental Activity, pay to the
Company in cash the difference between: 

  

	 	(i)	 Any amount actually paid therefor by the Participant pursuant to this Plan, and 

 

	 	(ii)	 The Market Value per Share of the Shares on the date the Shares were acquired or paid out.

  

	(d)	 To the extent that such amounts are not paid to the Company, the Company may set off the amounts so payable to
it against any amounts that may be owing from time to time by the Company or a Subsidiary to the Participant, whether as wages, retainer fees, deferred compensation or vacation pay or in the form of any other benefit or for any other reason.

 The remedies set forth in this Section 15 in the event that a Participant engages in a Detrimental Activity shall be in addition
to any and all other remedies that the Company may have against the Participant in that event and shall not be deemed exclusive remedies. The remedies set forth in this Section 15 also do not limit the remedies that the Company may be required
or permitted to exercise in respect of Participants pursuant to the provisions of Section 954 of the Wall Street Reform and Consumer Protection Act and the regulations thereunder. 

16. Non U.S. Participants. In order to facilitate the making of any grant or combination of grants under this Plan, the Board or the Chief Executive
Officer or his delegatee or delegatees, as applicable, may provide for such special terms for awards to Participants who are foreign nationals or who are employed by the Company or any Subsidiary outside of the United States of America or who
provide services to the Company under an agreement with a foreign nation or agency, as the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may consider necessary or appropriate to accommodate differences in local
law, tax policy or custom. Moreover, the Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may approve such supplements to or amendments, restatements or alternative versions of this Plan (including, without
limitation, sub-plans) as it may consider necessary or appropriate for such purposes, without thereby affecting the terms of this Plan as in effect for any other purpose, and the Secretary or other appropriate
officer of the Company may certify any such document as having been approved and adopted in the same manner as this Plan. No such special terms, supplements, amendments or restatements, however, will include any provisions that are inconsistent with
the terms of this Plan as then in effect unless this Plan could have been amended to eliminate such inconsistency without further approval by the shareholders of the Company. 

17. Transferability. 
  

	(a)	 Except as otherwise determined by the Board or the Chief Executive Officer or his delegatee or delegatees, as
applicable, no Option Right, Appreciation Right, Restricted Stock, Restricted Stock Unit, Performance Share, Performance Unit, award contemplated by Section 9 or 10 of this Plan, or dividend equivalents paid with respect to awards made under
the Plan shall be transferable by the Participant except by will or the laws of descent and distribution and, in no event shall any such award granted under the Plan be transferred for value. Except as otherwise determined by the Board or the Chief
Executive Officer or his delegatee or delegatees, as applicable, Option Rights and Appreciation Rights will be exercisable during the Participant’s lifetime only by him or her or, in the event of the Participant’s legal incapacity to do
so, by his or her guardian or legal representative acting on behalf of the Participant in a fiduciary capacity under state law and/or court supervision. 

  

	(b)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may specify at the Date
of Grant that part or all of the Shares that are (i) to be issued or transferred by the Company upon the exercise of Option Rights or Appreciation Rights, upon the termination of the Restriction Period applicable to Restricted Stock Units or
upon payment under any grant of Performance Shares or Performance Units or (ii) no longer subject to the substantial risk of forfeiture and restrictions on transfer referred to in Section 6 of this Plan, will be subject to further
restrictions on transfer. 

 18. Withholding Taxes. To the extent that the Company is required to withhold federal, state, local or
foreign taxes in connection with any payment made or benefit realized by a Participant or other person under this Plan, and 

  
 17 

 
the amounts available to the Company for such withholding are insufficient, it will be a condition to the receipt of such payment or the realization of such benefit that the Participant or such
other person make arrangements satisfactory to the Company for payment of the balance of such taxes required to be withheld, which arrangements (in the discretion of the Board or the Chief Executive Officer or his delegatee or delegatees, as
applicable) may include relinquishment of a portion of such benefit. If a Participant’s benefit is to be received in the form of Shares, and such Participant fails to make arrangements for the payment of tax, the Company shall withhold such
Shares having a value equal to the amount required to be withheld. Notwithstanding the foregoing, when a Participant is required to pay the Company an amount required to be withheld under applicable income and employment tax laws, the Participant
may elect, with the Company’s approval, to satisfy the obligation, in whole or in part, by electing to have withheld, from the shares required to be delivered to the Participant, Shares having a value equal to the amount required to be withheld
(except in the case of Restricted Stock where an election under Section 83(b) of the Code has been made), or by delivering to the Company other Shares held by such Participant. The shares used for tax withholding will be valued at an amount
equal to the Market Value per Share of such Shares on the date the benefit is to be included in the Participant’s income. In no event shall the Market Value per Share of the Shares to be withheld and/or delivered pursuant to this Section to
satisfy applicable withholding taxes in connection with the benefit exceed the minimum amount of taxes required to be withheld. Participants shall also make such arrangements as the Company may require for the payment of any withholding tax
obligation that may arise in connection with the disposition of Shares acquired upon the exercise of Option Rights. Notwithstanding the foregoing, the Company may, at any time, in its discretion, withhold for federal, state, local or foreign taxes
in connection with any payment made or benefit realized by a Participant or other person under this Plan. 
 19. Compliance with
Section 409A of the Code. 
  

	(a)	 To the extent applicable, it is intended that this Plan and any grants made hereunder comply with the
provisions of Section 409A of the Code. This Plan and any grants made hereunder shall be administrated in a manner consistent with this intent, and any provision that would cause this Plan or any grant made hereunder to fail to satisfy
Section 409A of the Code shall have no force and effect unless and until amended to comply with Section 409A of the Code (which amendment may be retroactive to the extent permitted by Section 409A of the Code and may be made by the
Company without the consent of Participants). Any reference in this Plan to Section 409A of the Code will also include any proposed, temporary or final regulations, or any other guidance, promulgated with respect to such Section by the U.S.
Department of the Treasury or the Internal Revenue Service. 

  

	(b)	 In order to determine for purposes of Section 409A of the Code whether a Participant is in the service of
a member of the Company’s controlled group of corporations under Section 414(b) of the Code (or by a member of a group of trades or businesses under common control with the Company under Section 414(c) of the Code) and, therefore,
whether the Shares that are or have been purchased by or awarded under this Plan to the Participant are shares of “service recipient” stock within the meaning of Section 409A of the Code: 

 

	 	(i)	 In applying Section 1563(a)(1), (2) and (3) of the Code for purposes of determining the
Company’s controlled group under Section 414(b) of the Code, the language “at least 50 percent” is to be used instead of “at least 80 percent” each place it appears in Section 1563(a)(1), (2) and (3) of the
Code, and 

  

	 	(ii)	 In applying Treasury Regulation Section 1.414(c)-2 for purposes of
determining trades or businesses under common control with the Company for purposes of Section 414(c) of the Code, the language “at least 50 percent” is to be used instead of “at least 80 percent” each place it appears in
Treasury Regulation Section 1.414(c)-2. 

 20. Amendments. 

 

	(a)	 The Board may at any time and from time to time amend this Plan in whole or in part; provided, however,
that if an amendment to this Plan (i) would materially increase the benefits accruing to Participants under this Plan, (ii) would materially increase the number of securities which may be issued under this Plan, (iii) would materially
modify the requirements for participation in this Plan or (iv) must otherwise be approved by the shareholders of the Company in order to comply with applicable law or the rules of the New York Stock Exchange or, if the Shares are not traded on
the New York Stock Exchange, the principal national securities exchange upon which the Shares are traded or quoted, then, such amendment will be subject to shareholder approval and will not be effective unless and until such approval has been
obtained. 

  
 18 

	(b)	 Neither the Board nor the Chief Executive Officer or his delegatee or delegatees, as applicable, will, without
the further approval of the shareholders of the Company, authorize the amendment of any outstanding Option Right or Appreciation Right to reduce the Option Price or Base Price, as applicable. Furthermore, no Option Right or Appreciation Right will
be cancelled and replaced with awards having a lower Option Price or Base Price without further approval of the shareholders of the Company. This Section 20(b) is intended to prohibit the repricing of “underwater” Option Rights and
Appreciation Rights and will not be construed to prohibit the adjustments provided for in Section 13 of this Plan. 

  

	(c)	 If permitted by Section 409A of the Code, in case of termination of service by reason of death, Disability
or normal or early retirement, or in the case of unforeseeable emergency or other special circumstances, of a Participant who holds an Option Right or Appreciation Right not immediately exercisable in full, or any shares of Restricted Stock as to
which the substantial risk of forfeiture or the prohibition or restriction on transfer has not lapsed, or any Restricted Stock Units as to which the Restriction Period has not been completed, or any Performance Shares or Performance Units which have
not been fully earned, or any other awards made pursuant to Section 10 subject to any vesting schedule or transfer restriction, or who holds Shares subject to any transfer restriction imposed pursuant to Section 17(b) of this Plan, the
Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may, in its sole discretion, accelerate the time at which such Option Right, Appreciation Right or other award may be exercised or the time at which such substantial
risk of forfeiture or prohibition or restriction on transfer will lapse or the time when such Restriction Period will end or the time at which such Performance Shares or Performance Units will be deemed to have been fully earned or the time when
such transfer restriction will terminate or may waive any other limitation or requirement under any such award. 

  

	(d)	 Subject to Section 20(b) hereof, the Board or the Chief Executive Officer or his delegatee or delegatees,
as applicable, may amend the terms of any award theretofore granted under this Plan prospectively or retroactively. Subject to Section 13 above, no such amendment shall impair the rights of any Participant without his or her consent. The Board
may, in its discretion, terminate this Plan at any time. Termination of this Plan will not affect the rights of Participants or their successors under any awards outstanding hereunder and not exercised in full on the date of termination.

 21. Governing Law. The Plan and all grants and awards and actions taken thereunder shall be governed by and construed in
accordance with the internal substantive laws of the State of Ohio. 
 22. Certain Additional Special Rules Concerning Vesting of Awards. Unless
otherwise provided in the relevant Evidence of Award (except that the provisions in this Section 22 regarding the treatment of awards of Participants who are or become Qualifying Service Termination Eligible shall apply to awards granted prior
to May 31, 2018 regardless of any other terms in the applicable Evidence of Award), each grant of Restricted Stock and Restricted Stock Units to any Participant who is not a Non-Employee Director shall be
subject to the following provisions, subject to the provisions of Section 11 hereof: 
  

	(a)	 If at the Date of Grant the Participant is Qualifying Retirement Eligible or Qualifying Service Termination
Eligible, the award shall vest and become nonforfeitable in four (4) equal annual installments, on each of the first through fourth anniversaries of the Date of Grant. 

 

	(b)	 If at the Date of Grant the Participant is not Qualifying Retirement Eligible or Qualifying Service Termination
Eligible, the award shall vest and become nonforfeitable on the fourth anniversary of the Date of Grant; provided, however, that if before the award has otherwise become vested and nonforfeitable pursuant to the foregoing provision the
Participant becomes Qualifying Retirement Eligible or Qualifying Service Termination Eligible, whichever occurs first, then on the anniversary of the Date of Grant that coincides with or immediately succeeds the date the Participant becomes
Qualifying Retirement Eligible or Qualifying Service Termination Eligible, as applicable, and provided the Participant has remained in the service of the Company or a Subsidiary through such anniversary, the award will become vested and
nonforfeitable to the same extent as it would have been on such date under paragraph (a) had the Participant been Qualifying Retirement Eligible or Qualifying Service Termination Eligible at the Date of Grant, and if such anniversary is not the
fourth anniversary of the Date of Grant, the award will thereafter continue to vest in the same manner and to the same extent as would have been the case under paragraph (a) had the Participant been Qualifying Retirement Eligible or Qualifying
Service Termination Eligible at the Date of Grant. 

  

	(c)	 Notwithstanding the foregoing, if any such anniversary on which an award or portion thereof would otherwise
vest is not a trading day on the New York Stock Exchange, such vesting shall be deferred until the first trading day thereafter. 

  
 19 

	(d)	 Not in limitation of the other forfeiture provisions contained in the Plan or the relevant Evidence of Award,
if the Participant terminates service with the Company and all Subsidiaries prior to the date on which the Participant’s award has become fully vested and nonforfeitable, and subject to the provisions of Section 11 of the Plan, those
portions of the award not vested at the time of such termination shall be forfeited. 

  

	(e)	 Also notwithstanding the foregoing, if on any anniversary of a Date of Grant any portion of an award that would
otherwise vest on that anniversary represents a fractional share, that portion shall be aggregated with any portions of the award that represent fractional shares and would otherwise vest on succeeding anniversary dates and all portions so
aggregated shall vest on the first of the aforesaid anniversary dates. 

  

	(f)	 Notwithstanding the foregoing or anything to the contrary contained herein or in the applicable Evidence of
Award, for the avoidance of doubt, the foregoing provisions of this Section 22 shall not apply to any Restricted Stock or Restricted Stock Units granted to any Participant if, at the time of the grant thereof, the application of such provisions
would violate applicable law because of the age requirement included in the Qualifying Retirement Eligible definition. 

  

	(g)	 For the avoidance of doubt, the provisions of this Section 22 do not apply to any Option Rights,
Appreciation Rights, Performance Shares, Performance Units or other awards granted pursuant to Section 10 hereof and do not apply to awards to Non-Employee Directors. 

23. Certain Additional Provisions Concerning Change in Control and Option Rights, Appreciation Rights, Restricted Stock and Restricted Stock Units.
Unless otherwise provided in the applicable Evidence of Award, the following provisions shall apply to Option Rights, Appreciation Rights, Restricted Stock and Restricted Stock Units: 

 

	(a)	 Upon a Change in Control occurring prior to such time as a Participant’s Option Right has become fully
exercisable and while the Participant is an employee of the Company or a Subsidiary, to the extent the Option has not then or theretofore been forfeited, the Option Right shall become immediately exercisable in full, except to the extent that a
Replacement Option Award is provided to the Participant for such Option Right effective concurrently with or prior to the Change in Control. For purposes of this Plan, a “Replacement Option Award” means an award (i) of stock options,
(ii) that has a value at least equal to the value of the Option Right being replaced, (iii) that relates to publicly traded equity securities of the Employer (as defined below), (iv) the tax consequences of which are not less favorable to
the Participant than the tax consequences of the Option Right being replaced, (v) that becomes exercisable in full upon a termination of the Participant’s employment with the Employer (A) by the Participant for Good Reason (as defined
below), or (B) by the Employer other than for Cause or any other Detrimental Activity, with the termination occurring in either case within a period of two years after the Change in Control, and (vi) the other terms and conditions of which
are not less favorable to the Participant than the terms and conditions of the Option Right being replaced (including the provisions that would apply in the event of a subsequent Change in Control). Without limiting the generality of the foregoing,
the Replacement Option Award may take the form of a continuation of the Option Right being replaced if the requirements of the preceding sentence are satisfied. The determination of whether the conditions of this Section 23(a) are satisfied
will be made by the Board, as constituted immediately before the Change in Control, in its sole discretion. 

  

	(b)	 Upon a Change in Control occurring prior to such time as a Participant’s Appreciation Right has become
fully exercisable and while the Participant is an employee of the Company or a Subsidiary, to the extent the Appreciation Right has not then or theretofore been forfeited, the Appreciation Right shall become immediately exercisable in full, except
to the extent that a Replacement Appreciation Right Award is provided to the Participant for such Appreciation Right effective concurrently with or prior to the Change in Control. For purposes of this Plan, a “Replacement Appreciation Right
Award” means an award (i) of stock appreciation rights, (ii) that has a value at least equal to the value of the Appreciation Right being replaced, (iii) that relates to publicly traded equity securities of the Employer,
(iv) the tax consequences of which are not less favorable to the Participant than the tax consequences of the Appreciation Right being replaced, (v) that becomes exercisable in full upon a termination of the Participant’s employment
with the Employer (A) by the Participant for Good Reason, or (B) by the Employer other than for Cause or any other Detrimental Activity, with the termination occurring in either case within a period of two years after the Change in
Control, and (vi) the other terms and conditions of which are not less favorable to the Participant than the terms and conditions of the Appreciation Right being replaced (including the provisions that would apply in the event of a subsequent
Change in Control). Without limiting the generality of the foregoing, the 

  
 20 

	 	
Replacement Appreciation Right Award may take the form of a continuation of the Appreciation Right being replaced if the requirements of the preceding sentence are satisfied. The determination of
whether the conditions of this Section 23(b) are satisfied will be made by the Board, as constituted immediately before the Change in Control, in its sole discretion. 

 

	(c)	 Upon a Change in Control occurring prior to such time as all substantial risks of forfeiture and restrictions
on transfer applicable to a Participant’s Restricted Stock have lapsed or terminated, and while the Participant is an employee of the Company or a Subsidiary, to the extent the Restricted Stock has not then or theretofore been forfeited, all of
such substantial risks of forfeiture and restrictions on transfer applicable to the Restricted Stock shall lapse and terminate, except to the extent that a Replacement Restricted Stock Award is provided to the Participant for such Restricted Stock
effective concurrently with or prior to the Change in Control. For purposes of this Plan, a “Replacement Restricted Stock Award” means an award (i) of restricted stock, (ii) that has a value at least equal to the value of the
Restricted Stock being replaced, (iii) that relates to publicly traded equity securities of the Employer, (iv) the tax consequences of which are not less favorable to the Participant than the tax consequences of the Restricted Stock being
replaced, (v) that provides that all substantial risks of forfeiture and restrictions on transfer applicable thereto shall lapse and terminate in full upon a termination of the Participant’s employment with the Employer (A) by the
Participant for Good Reason, or (B) by the Employer other than for Cause or any other Detrimental Activity, with the termination occurring in either case within a period of two years after the Change in Control, and (vi) the other terms
and conditions of which are not less favorable to the Participant than the terms and conditions of the Restricted Stock being replaced (including the provisions that would apply in the event of a subsequent Change in Control). Without limiting the
generality of the foregoing, the Replacement Restricted Stock Award may take the form of a continuation of the Restricted Stock being replaced if the requirements of the preceding sentence are satisfied. The determination of whether the conditions
of this Section 23(c) are satisfied will be made by the Board, as constituted immediately before the Change in Control, in its sole discretion. 

  

	(d)	 Upon a Change in Control occurring prior to such time as the Restriction Period applicable to any grant of a
Restricted Stock Unit to a Participant has lapsed or terminated, and while the Participant is an employee of the Company or a Subsidiary, to the extent the Restriction Period has not then or theretofore lapsed or terminated, the Restriction Period
shall lapse and terminate, except to the extent that a Replacement Restricted Stock Unit Award is provided to the Participant for such Restricted Stock Unit effective concurrently with or prior to the Change in Control. For purposes of this Plan, a
“Replacement Restricted Stock Unit Award” means an award (i) of restricted stock units, (ii) that has a value at least equal to the value of the Restricted Stock Unit being replaced, (iii) that relates to publicly traded
equity securities of the Employer, (iv) the tax consequences of which are not less favorable to the Participant than the tax consequences of the Restricted Stock Unit being replaced, (v) that provides that the Restriction Period shall
lapse and terminate in full upon a termination of the Participant’s employment with the Employer (A) by the Participant for Good Reason, or (B) by the Employer other than for Cause or any other Detrimental Activity, with the
termination occurring in either case within a period of two years after the Change in Control, and (vi) the other terms and conditions of which are not less favorable to the Participant than the terms and conditions of the Restricted Stock Unit
being replaced (including the provisions that would apply in the event of a subsequent Change in Control). Without limiting the generality of the foregoing, the Replacement Restricted Stock Unit Award may take the form of a continuation of the
Restricted Stock Unit being replaced if the requirements of the preceding sentence are satisfied. The determination of whether the conditions of this Section 23(d) are satisfied will be made by the Board, as constituted immediately before the
Change in Control, in its sole discretion. 

  

	(e)	 For purposes of the Plan, except as may be otherwise prescribed by the Board or Chief Executive Officer or his
delegatee or delegatees, as applicable, in an Evidence of Award made under the Plan, the term “Good Reason” means with respect to a Participant: 

  

	 	(i)	 the Employer fails to make any payment when due of the Participant’s Base Salary (as defined below) or any
incentive compensation to which the Participant is entitled; 

  

	 	(ii)	 any material decrease in the Participant’s rate of Base Salary or a material reduction of the
Participant’s maximum incentive compensation opportunity; 

  

	 	(iii)	 the Employer requires the Participant to work out of an office that is more than 50 miles away from the
Participant’s office location at the time of the Change in Control for more than 30 consecutive days; or 

  
 21 

	 	(iv)	 the Disability or death of the Participant; 

and in each case the Participant has provided the Employer with written notice within thirty (30) days after the initial event which the
Participant believes constitutes “Good Reason,” describing such event, and, in the case of events other than those described in clause (iv), the Employer has failed to remedy the situation within thirty (30) days after receipt of
notice. 
  

	(f)	 For purposes of the Plan, the term “Base Salary” means, at any time, the then regular gross annual
rate of salary payable to a Participant as annual salary, including amounts withheld or deferred for any reason, including any amounts not includible in income for U.S. federal income tax purposes as a result of elections by the Participant or the
Employer that would have been includible in income absent such elections. 

  

	(g)	 For purposes of the Plan, the term “Employer” means the Company or its successor in the Change in
Control (or another entity that is affiliated with the Company or its successor following the Change in Control). In addition, following a Change in Control, to the extent that a provision of the Plan references the Company, such reference shall be
deemed to be a reference to the Employer where appropriate in the context. 

  

	(h)	 For purposes of the Plan, except as may be otherwise prescribed by the Board or Chief Executive Officer or his
delegate or delegates, as applicable, in an Evidence of Award made under the Plan, the term “Disability” shall have the meaning used for purposes of the Employer’s long-term disability plan as in effect at the time the Disability is
claimed to have occurred. 

 24. Miscellaneous Provisions. 

 

	(a)	 The Company will not be required to issue any fractional Shares pursuant to this Plan. The Board or the Chief
Executive Officer or his delegatee or delegatees, as applicable, may provide for the elimination of fractions or for the settlement of fractions in cash. 

  

	(b)	 This Plan will not confer upon any Participant any right with respect to continuance of employment or other
service with the Company or any Subsidiary, nor will it interfere in any way with any right the Company or any Subsidiary would otherwise have to terminate such Participant’s employment or other service at any time. 

 

	(c)	 To the extent that any provision of this Plan would prevent any Option Right that was intended to qualify as an
Incentive Stock Option from qualifying as such, that provision will be null and void with respect to such Option Right. Such provision, however, will remain in effect for other Option Rights and there will be no further effect on any provision of
this Plan. 

  

	(d)	 No award under this Plan may be exercised by the holder thereof if such exercise, and the receipt of cash or
stock thereunder, would be, in the opinion of counsel selected by the Board, contrary to law or the regulations of any duly constituted authority having jurisdiction over this Plan. 

 

	(e)	 Absence on leave approved by a duly constituted officer of the Company shall not be considered interruption or
termination of service of any employee for any purposes of this Plan or awards granted hereunder, except that no awards may be granted to an employee while he or she is absent on leave. 

 

	(f)	 No Participant shall have any rights as a stockholder with respect to any shares subject to awards granted to
him or her under this Plan prior to the date as of which he or she is actually recorded as the holder of such shares upon the stock records of the Company. 

  

	(g)	 The Board or the Chief Executive Officer or his delegatee or delegatees, as applicable, may condition the grant
of any award or combination of awards authorized under this Plan on the surrender or deferral by the Participant of his or her right to receive a cash bonus or other compensation otherwise payable by the Company or a Subsidiary to the Participant.

  

	(h)	 If any provision of this Plan is or becomes invalid or unenforceable in any jurisdiction, or would disqualify
this Plan or any award under any law deemed applicable by the Board, such provision shall be construed or deemed amended or limited in scope to conform to applicable laws or, in the discretion of the Board, it shall be stricken and the remainder of
this Plan shall remain in full force and effect. 

  
 22

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00294-of-00352.parquet"}]]